https://curecurrent.com/trials/vietnam-cryptococcal-retention-in-care-study-version-2-1-131009https://curecurrent.com/trials/impact-of-antiretroviral-treatment-on-pharmacokinetics-and-pharmacodynamics-of-thienopyridines-in-healthy-volunteers-and-131010https://curecurrent.com/trials/relative-bioavailability-study-with-bms-955176-131011https://curecurrent.com/trials/a-drug-interaction-study-evaluating-gsk2248761-and-raltegravir-pharmacokinetics-in-healthy-adult-subjects-131012https://curecurrent.com/trials/a-study-to-assess-the-effect-of-high-fat-meal-and-increased-gastric-ph-on-the-bioavailability-of-an-extended-release-for-131013https://curecurrent.com/trials/bioavailability-of-bms-626529-in-healthy-subjects-from-prototype-low-dose-extended-release-formulations-part-1-and-proto-131014https://curecurrent.com/trials/ddi-potential-dapivirine-vaginal-ring-and-miconazole-nitrate-131015https://curecurrent.com/trials/safety-and-pharmacokinetic-trial-in-healthy-hiv-negative-women-to-assess-the-delivery-of-dapivirine-from-a-vaginal-ring-131016https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-of-an-adenovirus-based-hiv-vaccine-in-hiv-uninfected-adults-131017https://curecurrent.com/trials/reversing-the-epidemic-in-africa-with-choices-in-hiv-prevention-reach-131018https://curecurrent.com/trials/assessing-the-safety-of-dapivirine-gel-and-film-formulations-131019https://curecurrent.com/trials/safety-and-pharmacokinetic-study-of-oral-maraviroc-and-maraviroc-1-gel-in-hiv-1-seronegative-adults-131020https://curecurrent.com/trials/evaluating-bmd-in-participants-50-years-old-switching-from-evg-cobi-ftc-taf-or-evg-cobi-ftc-tdf-to-abc-dtg-3tc-131021https://curecurrent.com/trials/safety-and-acceptability-study-of-prepex-device-when-removing-the-foreskin-shortly-after-placement-of-device-131022https://curecurrent.com/trials/a-trial-in-healthy-hiv-negative-women-to-assess-the-effect-of-menses-and-tampon-use-on-the-pharmacokinetics-of-dapivirin-131023https://curecurrent.com/trials/bevacizumab-to-treat-kaposi-s-sarcoma-in-hiv-positive-and-hiv-negative-patients-131024https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-genetic-factors-on-the-pharmacokinetics-of-antiretroviral-drugs-during-pregnancy-and-131025https://curecurrent.com/trials/metabolic-effects-of-non-thymidine-analogue-anti-hiv-medications-131026https://curecurrent.com/trials/effectiveness-of-antiretroviral-therapy-during-acute-hiv-infection-131027https://curecurrent.com/trials/the-effect-of-raltegravir-on-hiv-decay-during-primary-and-chronic-infection-131028https://curecurrent.com/trials/healthmap-an-interactive-health-plan-randomised-trial-to-prevent-cardiovascular-disease-in-people-with-hiv-131029https://curecurrent.com/trials/to-assess-the-drug-drug-interaction-potential-between-dapivirine-vaginal-ring-004-containing-25-mg-of-dapivirine-and-clo-131030https://curecurrent.com/trials/stopping-tdf-treatment-after-long-term-virologic-suppression-in-hbeag-negative-chb-131031https://curecurrent.com/trials/mindful-living-with-stress-for-nurses-caring-for-hiv-aids-patients-in-china-131032https://curecurrent.com/trials/safety-and-efficacy-of-allogenic-adoptive-immune-therapy-for-advanced-aids-patients-131033https://curecurrent.com/trials/micronutrient-supplemented-probiotic-yogurt-for-hiv-aids-and-other-immunodeficiencies-131034https://curecurrent.com/trials/culturally-congruent-hiv-risk-reduction-app-for-young-women-an-acceptability-pilot-evaluation-131035https://curecurrent.com/trials/promoting-antiretroviral-therapy-among-serodiscordant-couples-to-reduce-hiv-transmission-131036https://curecurrent.com/trials/preventing-health-damaging-behaviors-in-male-and-female-army-recruits-131037https://curecurrent.com/trials/evaluate-the-safety-assess-local-and-systemic-pk-of-ds003-vaginal-tablets-administered-to-healthy-hiv-negative-women-131038https://curecurrent.com/trials/monitoring-liver-disease-progression-in-hepatitis-c-hiv-co-infected-patients-with-no-to-moderate-fibrosis-in-phnom-penh-131039https://curecurrent.com/trials/nutritional-therapy-improves-dyslipidemia-in-hiv-infected-teenagers-with-antiretroviral-treatment-131040https://curecurrent.com/trials/observational-study-for-the-extended-follow-up-of-the-patients-enrolled-in-the-therapeutic-clinical-trial-iss-t-002-131041https://curecurrent.com/trials/effect-of-supplementation-with-glutamine-and-exercise-in-women-with-hiv-aids-131042https://curecurrent.com/trials/a-trial-evaluating-maintenance-therapy-with-lamivudine-epivir-and-dolutegravir-tivicay-in-human-immunodeficiency-virus-1-131043https://curecurrent.com/trials/cognitive-processing-intervention-for-trauma-hiv-sti-risks-and-substance-use-among-native-women-131044https://curecurrent.com/trials/prospective-epidemiological-study-of-the-prevalence-of-hlab-5701-in-hiv-1-infected-patients-131045https://curecurrent.com/trials/evaluation-of-raltegravir-during-the-third-trimester-of-pregnancy-131046https://curecurrent.com/trials/measurement-of-plasma-and-intracellular-concentrations-of-raltegravir-131047https://curecurrent.com/trials/lopinavir-r-or-fosamprenavir-r-switch-to-atazanavir-r-or-darunavir-r-131048https://curecurrent.com/trials/screening-for-tb-in-pregnancy-on-hiv-infected-pregnant-women-131049https://curecurrent.com/trials/prep-impact-trial-a-pragmatic-health-technology-assessment-of-prep-and-implementation-131050https://curecurrent.com/trials/chepetsa-tb-reducing-tb-among-hiv-infected-malawians-131051https://curecurrent.com/trials/pharmacokinetic-characteristics-and-anti-inflammatory-effects-of-aprepitant-in-hiv-infected-subjects-131052https://curecurrent.com/trials/management-and-optimization-of-nutrition-antenatal-reproductive-child-health-hiv-care-131053https://curecurrent.com/trials/integrating-hiv-and-hepatitis-c-screening-in-an-urban-emergency-department-131054https://curecurrent.com/trials/transplantation-and-the-use-of-raltegravir-in-hiv-infected-patients-131055https://curecurrent.com/trials/safety-pharmacokinetics-and-acceptability-of-pc-1005-for-vaginal-use-131056https://curecurrent.com/trials/efficacy-study-of-the-vaginal-gel-carraguard-to-prevent-hiv-transmission-131057https://curecurrent.com/trials/a-randomized-controlled-cross-over-trial-of-safety-of-vaginal-use-of-carraguard-by-hiv-infected-women-131058https://curecurrent.com/trials/addressing-gender-based-violence-in-hiv-testing-and-counseling-131059https://curecurrent.com/trials/safety-acceptability-and-preliminary-effectiveness-of-pc-515-for-vaginal-use-as-a-possible-microbicide-131060https://curecurrent.com/trials/safety-acceptability-and-preliminary-effectiveness-of-carraguard-pc-515-in-preventing-hiv-sti-transmission-131061https://curecurrent.com/trials/dolutegravir-lamivudine-as-dual-therapy-in-naive-hiv-infected-patients-a-pilot-study-131062https://curecurrent.com/trials/safety-and-acceptability-of-carraguard-among-hiv-negative-couples-in-thailand-131063https://curecurrent.com/trials/safety-and-acceptability-of-carraguard-in-hiv-positive-women-and-men-131064https://curecurrent.com/trials/switching-from-efavirenz-to-atazanavir-ritonavir-in-hiv-infected-subjects-with-good-virologic-suppression-131065https://curecurrent.com/trials/analysis-of-genetic-factors-which-may-influence-the-course-of-hiv-infection-131066https://curecurrent.com/trials/a-study-to-assess-the-drug-drug-interaction-of-bms-663068-with-methadone-and-also-with-buprenorphine-naloxone-131067https://curecurrent.com/trials/analysis-of-the-impact-of-hcv-treatment-by-last-generation-direct-antiviral-agents-daa-on-antiviral-immunity-and-hiv-dna-131068https://curecurrent.com/trials/a-study-to-determine-the-effect-of-multiple-doses-of-bms-955176-on-the-electrocardiograph-of-healthy-subjects-131069https://curecurrent.com/trials/ddi-study-of-bms-663068-with-etravirine-etr-and-or-darunavir-dvr-ritonavir-rtv-131070https://curecurrent.com/trials/assessing-strategies-for-increasing-male-involvement-in-malawi-s-antenatal-program-131071https://curecurrent.com/trials/relative-bioavailability-study-of-a-fixed-dose-combination-dolutegravir-abacavir-lamivudine-dispersible-tablet-131072https://curecurrent.com/trials/optimizing-clinical-outcomes-in-hiv-infected-adults-children-131073https://curecurrent.com/trials/gsk706769-repeat-dose-study-131074https://curecurrent.com/trials/serological-survey-on-monitoring-the-positive-rate-after-vaccination-of-inactivated-polio-vaccine-131075https://curecurrent.com/trials/synbiotics-in-advanced-hiv-infection-131076https://curecurrent.com/trials/motivational-enhancement-system-for-adherence-131077https://curecurrent.com/trials/testing-a-secondary-prevention-intervention-for-hiv-positive-black-young-men-who-have-sex-with-men-131078https://curecurrent.com/trials/atripla-to-stribild-switch-study-to-evaluate-sleep-disturbances-131079https://curecurrent.com/trials/advanced-neuroimaging-evaluation-of-the-central-nervous-system-biological-changes-associated-with-efavirenz-therapy-and-131080https://curecurrent.com/trials/does-micro-albuminuria-is-a-predictive-factor-for-cognitive-impairment-in-persons-living-with-hiv-plhiv-who-achieve-cart-131081https://curecurrent.com/trials/effect-of-repeated-exposures-to-compressed-air-on-patients-with-aids-131082https://curecurrent.com/trials/a-drug-drug-interaction-study-between-bms-663068-and-oral-contraceptives-in-healthy-female-volunteers-ddi-131083https://curecurrent.com/trials/study-to-evaluate-the-effect-of-food-on-the-pharmacokinetics-of-bms-626529-131084https://curecurrent.com/trials/early-infant-diagnosis-point-of-care-pilot-131085https://curecurrent.com/trials/a-pilot-study-to-assess-the-feasibility-of-switching-individuals-receiving-atripla-with-continuing-central-nervous-syste-131086https://curecurrent.com/trials/advanced-neuroimaging-evaluation-of-cns-changes-associated-with-efavirenz-therapy-switch-to-an-raltegravir-based-regimen-131087https://curecurrent.com/trials/methadone-maintenance-treatment-mmt-care-for-hiv-prevention-131088https://curecurrent.com/trials/changes-in-liver-steatosis-after-switching-to-raltegravir-in-hiv-hcv-coinfection-131089https://curecurrent.com/trials/the-compartmental-biology-of-hiv-in-the-male-genital-tract-131090https://curecurrent.com/trials/batar-individuals-currently-taking-boosted-atazanavir-as-part-of-an-hiv-treatment-regimen-will-be-evaluated-to-see-if-su-131091https://curecurrent.com/trials/individual-and-contextual-factors-that-influence-sexual-decisions-131092https://curecurrent.com/trials/absolute-bioavailability-of-bms-626529-after-oral-and-intravenous-dosing-131093https://curecurrent.com/trials/gsk706769-kaletra-drug-drug-interaction-study-131094https://curecurrent.com/trials/russia-prevent-hiv-prevention-partnership-in-russian-alcohol-treatment-131095https://curecurrent.com/trials/evaluation-of-a-maintenance-strategy-with-protease-inhibitors-with-or-without-lamivudine-in-virologically-suppressed-hiv-131096https://curecurrent.com/trials/project-hermitage-hiv-prevention-in-hospitalized-russian-drinkers-131097https://curecurrent.com/trials/efficacy-study-of-substitution-of-darunavir-ritonavir-drv-r-for-dual-boosted-protease-inhibitors-131098https://curecurrent.com/trials/early-antiretroviral-therapy-and-pre-exposure-prophylaxis-for-hiv-prevention-among-female-sex-workers-in-cotonou-benin-131099https://curecurrent.com/trials/four-arm-randomized-control-trial-of-brief-mi-versus-couples-based-hiv-sti-prevention-in-south-africa-131100https://curecurrent.com/trials/a-clinical-trial-of-systemchange-to-improve-exercise-diet-and-health-in-hiv-infected-adults-131101https://curecurrent.com/trials/human-immunodeficiency-virus-hiv-postexposure-prophylaxis-pep-with-darunavir-ritonavir-drv-r-131102https://curecurrent.com/trials/telephone-support-to-improve-adherence-to-anti-hiv-medications-131103https://curecurrent.com/trials/immunologic-response-of-hepatitis-b-vaccine-131104https://curecurrent.com/trials/evaluation-of-the-prepex-device-for-rapid-scale-up-of-vmmc-phase-3-field-implementation-trial-with-hiv-adult-males-131105https://curecurrent.com/trials/hiv-prevention-program-for-african-american-teen-males-131106https://curecurrent.com/trials/a-stage-2-cognitive-behavioral-trial-reduce-alcohol-first-in-kenya-intervention-131107https://curecurrent.com/trials/effect-of-valacyclovir-in-the-reduction-of-hsv-2-recurrence-and-shedding-131108https://curecurrent.com/trials/provider-and-peer-support-intervention-to-improve-art-adherence-among-kenyan-men-who-have-sex-with-men-131109https://curecurrent.com/trials/impact-of-antiretroviral-therapy-on-cardiac-biomarkers-131110https://curecurrent.com/trials/interaction-between-high-dose-rifampicine-and-efavirenz-in-pulmonary-tuberculosis-and-hiv-co-infection-131111https://curecurrent.com/trials/hbv-vaccination-in-hiv-infected-adults-131112https://curecurrent.com/trials/prepception-expanding-assisted-reproductive-options-for-serodiscordant-couples-131113https://curecurrent.com/trials/comprehensive-hiv-prevention-package-for-msm-in-port-elizabeth-131114https://curecurrent.com/trials/an-open-label-non-randomized-dose-escalating-trial-to-assess-safety-and-tolerability-of-alb-interferon-alfa-2b-every-two-131115https://curecurrent.com/trials/specimens-from-normal-controls-131116https://curecurrent.com/trials/changes-in-hiv-viral-load-in-patients-undergoing-treatment-for-filariasis-131117https://curecurrent.com/trials/study-of-tests-to-evaluate-effectiveness-of-anti-hiv-drugs-131118https://curecurrent.com/trials/vaccine-treatment-for-hiv-infection-131119https://curecurrent.com/trials/evaluation-of-brain-lesions-in-hiv-infected-patients-for-diagnosis-of-primary-central-nervous-system-lymphoma-131120https://curecurrent.com/trials/analysis-of-hiv-genetic-variation-in-patients-before-beginning-highly-active-antiretroviral-therapy-131121https://curecurrent.com/trials/phase-i-study-of-vaccination-schedule-of-experimental-hiv-vaccines-131122https://curecurrent.com/trials/hiv-1-vaccine-booster-in-previously-immunized-uninfected-adult-volunteers-131123https://curecurrent.com/trials/safety-and-immune-response-to-a-prime-boost-vaccination-schedule-in-hiv-infected-patients-131124https://curecurrent.com/trials/evaluation-of-the-association-of-polymorphisms-in-the-innate-immune-system-with-the-risk-for-cryptococcus-neoformans-inf-131125https://curecurrent.com/trials/hiv-1-vaccine-test-in-uninfected-adult-volunteers-131126https://curecurrent.com/trials/effect-of-genetics-on-metabolism-of-efavirenz-131127https://curecurrent.com/trials/evaluation-and-monitoring-of-patients-with-hiv-infectionn-131128https://curecurrent.com/trials/validation-of-system-for-monitoring-the-effectiveness-of-antiretroviral-therapy-in-hiv-infected-patients-in-africa-131129https://curecurrent.com/trials/pharmacokinetic-interactions-with-prednisolone-in-healthy-volunteers-and-hiv-infected-patients-receiving-single-dose-pre-131130https://curecurrent.com/trials/differences-in-blood-levels-of-nevirapine-in-hiv-infected-patients-in-uganda-and-the-united-states-131131https://curecurrent.com/trials/decision-making-of-hispanics-and-african-americans-with-hiv-aids-participating-in-clinical-trials-131132https://curecurrent.com/trials/screening-hiv-infected-patients-for-vaccine-studies-131133https://curecurrent.com/trials/in-vitro-study-of-peripheral-blood-mononuclear-cell-function-in-healthy-individuals-and-patients-131134https://curecurrent.com/trials/effects-of-anti-hiv-therapy-on-red-blood-cells-of-hiv-infected-mothers-and-their-infants-131135https://curecurrent.com/trials/prime-boost-vaccine-schedule-for-prevention-of-hiv-infection-131136https://curecurrent.com/trials/impact-of-a-human-papilloma-virus-hpv-vaccine-in-hiv-infected-young-women-131137https://curecurrent.com/trials/safety-and-immunogenicity-of-an-hiv-vaccine-in-normal-adult-volunteers-131138https://curecurrent.com/trials/hla-and-kir-associations-with-infectious-viral-agents-in-an-hiv-cohort-of-women-wihs-131139https://curecurrent.com/trials/use-of-bromodeoxyuridine-to-study-white-blood-cell-replication-and-survival-in-hiv-infected-patients-131140https://curecurrent.com/trials/daclizumab-to-treat-hiv-infected-patients-131141https://curecurrent.com/trials/the-interaction-of-two-hiv-medications-with-blood-clot-medications-in-healthy-volunteers-131142https://curecurrent.com/trials/clinical-laboratory-and-epidemiologic-pilot-studies-of-individuals-at-high-risk-for-viral-associated-cancers-131143https://curecurrent.com/trials/use-of-combined-antiretroviral-therapy-to-determine-sites-of-persistent-hiv-infection-131144https://curecurrent.com/trials/immune-responses-to-hiv-in-blood-cells-in-hiv-infected-and-hiv-uninfected-volunteers-131145https://curecurrent.com/trials/influence-of-the-mdr1-genotype-on-blood-levels-of-indinavir-and-saquinavir-in-healthy-volunteers-131146https://curecurrent.com/trials/effect-of-leflunomide-on-t-cell-proliferation-in-hiv-infected-patients-131147https://curecurrent.com/trials/bravo-background-regimen-of-raltegravir-on-virologic-outcome-131148https://curecurrent.com/trials/candidate-hiv-vaccine-131149https://curecurrent.com/trials/the-effect-of-vorinostat-on-hiv-rna-expression-in-the-resting-cd4-t-cells-of-hiv-pts-on-stable-art-131150https://curecurrent.com/trials/toll-like-receptor-9-agonist-treatment-in-chronic-hiv-1-infection-131151https://curecurrent.com/trials/pilot-study-to-assess-efficacy-and-safety-of-sofosbuvir-ledipasvir-fixed-dose-combination-in-treatment-experienced-subje-131152https://curecurrent.com/trials/effect-of-antacids-on-the-pharmacokinetics-of-raltegravir-131153https://curecurrent.com/trials/improving-memory-performance-by-applying-cognitive-training-131154https://curecurrent.com/trials/corticosteroids-therapy-and-pneumocystis-jirovecii-pneumonia-pcp-131155https://curecurrent.com/trials/the-pharmacology-aging-clinic-131156https://curecurrent.com/trials/renal-integrase-study-131157https://curecurrent.com/trials/an-interactive-game-for-hiv-prevention-in-early-adolescents-131158https://curecurrent.com/trials/study-in-healthy-volunteers-of-the-safety-and-metabolism-of-different-doses-of-the-anti-hiv-drug-tmc278la-131159https://curecurrent.com/trials/managing-medications-131160https://curecurrent.com/trials/pharmacokinetics-of-efavirenz-in-the-presence-of-rifampicin-and-isoniazid-131161https://curecurrent.com/trials/impact-of-sbi-a-medical-food-on-nutritional-status-in-patients-with-hiv-associated-enteropathy-131162https://curecurrent.com/trials/a-48-week-study-comparing-treatment-with-saquinavir-lopinavir-ritonavir-in-combination-with-enfuvirtide-haart-versus-saq-131163https://curecurrent.com/trials/a-phase-iv-open-label-single-arm-study-investigating-the-pharmacokinetics-and-pharmacodynamics-of-the-antiretroviral-com-131164https://curecurrent.com/trials/naltrexone-for-medication-compliance-among-hiv-infected-men-with-alcohol-use-disorder-131165https://curecurrent.com/trials/ccrc-a-project-of-the-treatment-of-hiv-enteropathy-with-immunolin-supplements-131166https://curecurrent.com/trials/a-pilot-study-to-determine-if-raltegravir-eradicates-hiv-from-peripheral-blood-mononuclear-cells-131167https://curecurrent.com/trials/pilot-study-of-oral-probiotic-bacteria-supplementation-to-reduce-chronic-immune-activation-in-hiv-infected-malian-women-131168https://curecurrent.com/trials/hiv-reservoir-dynamics-after-switching-to-dolutegravir-in-patients-on-a-pi-and-2-nrti-based-regimen-131169https://curecurrent.com/trials/evolution-of-plasma-lipid-profile-in-patients-with-hiv1-who-change-atripla-to-eviplera-compared-to-continue-with-atripla-131170https://curecurrent.com/trials/hiv-prevention-in-the-primary-care-setting-131171https://curecurrent.com/trials/vaccination-of-hiv-1-infected-patients-with-dendritic-cells-in-addition-to-antiretroviral-treatment-dalia-trial-131172https://curecurrent.com/trials/mathematical-modeling-of-the-hiv-transmission-risk-after-initiation-of-antiretroviral-therapy-in-na-ve-hiv-infected-131173https://curecurrent.com/trials/gsk1349572-relative-bioavailability-study-131174https://curecurrent.com/trials/influence-of-antiretroviral-regimen-on-immune-reconstitution-in-the-female-genital-tract-131175https://curecurrent.com/trials/polypharmacy-and-clinically-significant-drug-interactions-among-hiv-infected-patients-receiving-antiretroviral-therapy-131176https://curecurrent.com/trials/study-of-paroxetine-and-fluconazole-for-the-treatment-of-hiv-associated-neurocognitive-disorder-131177https://curecurrent.com/trials/phase-1-open-label-two-arm-fixed-sequence-study-to-evaluate-the-effect-of-rifampin-and-rifabutin-on-gsk1349572-pharmacok-131178https://curecurrent.com/trials/a-study-to-assess-the-relative-bioavailability-of-tablet-formulations-of-gsk2248761-in-healthy-adult-subjects-sgn114435-131179https://curecurrent.com/trials/effectiveness-of-nucleoside-supplementation-or-switch-to-tenofovir-in-reversing-fat-loss-in-hiv-infected-adults-131180https://curecurrent.com/trials/home-self-testing-for-hiv-to-increase-hiv-testing-frequency-in-men-who-have-sex-with-men-the-itest-study-131181https://curecurrent.com/trials/translation-of-basic-research-in-cognitive-science-to-hiv-risk-131182https://curecurrent.com/trials/fractures-stratified-by-hiv-and-antiretroviral-therapy-art-status-131183https://curecurrent.com/trials/penta-fosamprenavir-study-131184https://curecurrent.com/trials/cohort-study-of-volunteers-that-have-participated-to-preventive-hiv-1-vaccine-trials-131185https://curecurrent.com/trials/effects-of-training-caregivers-on-the-outcomes-of-stroke-survivors-and-caregivers-in-zimbabwe-131186https://curecurrent.com/trials/testing-for-tuberculosis-in-the-united-kingdom-hiv-infected-population-131187https://curecurrent.com/trials/immunomodulating-therapy-and-improved-vaccination-responses-by-cox-2-inhibitor-in-hiv-infected-patients-131188https://curecurrent.com/trials/alcohol-pharmacotherapy-for-hiv-prisoners-131189https://curecurrent.com/trials/a-pilot-project-of-virologic-pharmacologic-and-immunologic-correlates-of-gastrointestinal-associated-lymphoid-tissue-imm-131190https://curecurrent.com/trials/a-dose-ranging-study-of-gw640385-boosted-with-ritonavir-rtv-in-comparison-to-a-rtv-boosted-protease-inhibitor-pi-in-hiv-131191https://curecurrent.com/trials/observational-study-of-a-protease-inhibitor-pi-containing-regimen-in-subjects-with-pi-mutations-selected-during-prior-tr-131192https://curecurrent.com/trials/effects-of-l-carnitine-on-postprandial-clearance-of-triglyceride-rich-lipoproteins-in-hiv-patients-on-haart-131193https://curecurrent.com/trials/gw873140-in-combination-with-kaletra-in-hiv-infected-subjects-131194https://curecurrent.com/trials/pilot-project-of-virologic-and-immunologic-correlates-of-galt-immune-reconstitution-following-raltegravir-therapy-131195https://curecurrent.com/trials/gw873140-in-combination-with-combivir-in-hiv-infected-subjects-131196https://curecurrent.com/trials/gw640385-plus-ritonavir-and-nrtis-for-48-weeks-in-hiv-1-infected-adults-131197https://curecurrent.com/trials/effect-of-seminal-fluid-on-the-colon-wall-implications-for-hiv-transmission-131198https://curecurrent.com/trials/immune-response-after-stem-cell-transplant-in-hiv-positive-patients-with-hematologic-cancer-131199https://curecurrent.com/trials/a-study-comparing-the-safety-tolerability-and-efficacy-of-trizivir-vs-combivir-atazanavir-in-subjects-with-hiv-131200https://curecurrent.com/trials/fludarabine-and-total-body-irradiation-followed-by-donor-stem-cell-transplant-and-cyclosporine-and-mycophenolate-mofetil-131201https://curecurrent.com/trials/safety-of-transplantation-of-crispr-ccr5-modified-cd34-cells-in-hiv-infected-subjects-with-hematological-malignances-131202https://curecurrent.com/trials/study-of-cell-phone-sms-to-improve-adherence-to-art-in-hiv-positive-young-women-131203https://curecurrent.com/trials/cambodia-integrated-hiv-and-drug-prevention-implementation-program-131204https://curecurrent.com/trials/study-on-the-usage-dosing-tolerability-and-effectiveness-of-kaletra-tablet-131205https://curecurrent.com/trials/a-retrospective-analysis-of-raltegravir-use-in-minority-hiv-infected-women-in-houston-texas-131206https://curecurrent.com/trials/trial-of-citalopram-for-the-prevention-of-depression-131207https://curecurrent.com/trials/prep-smart-phase-i-trial-131208https://curecurrent.com/trials/kaletra-in-combination-with-antiretroviral-agents-131209https://curecurrent.com/trials/women-focused-hiv-prevention-in-the-western-cape-131210https://curecurrent.com/trials/a-comparison-of-valganciclovir-and-ganciclovir-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-131211https://curecurrent.com/trials/switching-strategy-with-raltegravir-abc-3tc-in-controlled-hiv-1-infection-131212https://curecurrent.com/trials/anti-d-for-treating-thrombocytopenia-in-adults-infected-with-hepatitis-c-virus-with-or-without-hiv-co-infection-131213https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-asunaprevir-and-daclatasvir-in-subjects-coinfected-with-hiv-hcv-131214https://curecurrent.com/trials/treatment-of-acute-hiv-with-emtricitabine-tenofovir-and-efavirenz-cid-0805-131215https://curecurrent.com/trials/atazanavir-and-endothelial-function-in-older-hiv-patients-131216https://curecurrent.com/trials/life-course-hiv-and-hepatitis-b-among-african-migrants-living-in-ile-de-france-131217https://curecurrent.com/trials/a-novel-neurorehabilitation-approach-for-cognitive-aging-with-hiv-131218https://curecurrent.com/trials/a-phase-iv-open-label-4-period-cross-over-study-to-investigate-a-drug-interaction-between-lamivudine-and-sorbitol-oral-s-131219https://curecurrent.com/trials/a-study-of-the-relative-bioavailability-of-bms-626529-administered-as-bms-663068-from-150mg-low-dose-extended-release-ta-131220https://curecurrent.com/trials/a-single-dose-pharmacokinetic-pk-and-safety-study-of-gsk2838232-with-and-without-ritonavir-rtv-conducted-in-healthy-subj-131221https://curecurrent.com/trials/assessment-of-cognitive-functioning-as-it-relates-to-risk-for-suicide-in-veterans-with-hiv-aids-131222https://curecurrent.com/trials/china-antiretroviral-treatment-adherence-for-life-131223https://curecurrent.com/trials/intensvih-impact-of-therapy-intensification-by-an-integrase-inhibitor-ccr5-inhibitor-on-the-lymphoid-reservoir-for-hiv-1-131224https://curecurrent.com/trials/genotyping-fc-rs-genes-of-hiv-1-patients-progressor-correlation-with-the-changing-profile-of-the-infection-131225https://curecurrent.com/trials/on-demand-antiretroviral-pre-exposure-prophylaxis-for-hiv-infection-in-men-who-have-sex-with-men-131226https://curecurrent.com/trials/randomized-placebo-controlled-study-of-leptin-for-the-treatment-of-hiv-lipodystrophy-and-metabolic-syndrome-131227https://curecurrent.com/trials/pharmacokinetics-of-lopinavir-ritonavir-superboosting-in-infants-and-young-children-co-infected-with-hiv-and-tb-131228https://curecurrent.com/trials/roll-over-protocol-to-provide-atv-and-or-truvada-for-extended-access-131229https://curecurrent.com/trials/using-incentives-to-improve-parolee-participation-and-attendance-in-community-treatment-131230https://curecurrent.com/trials/effectiveness-of-modafinil-for-treating-fatigue-in-adults-with-hiv-aids-131231https://curecurrent.com/trials/screening-brief-intervention-and-referral-to-treatment-for-offenders-131232https://curecurrent.com/trials/biomarkers-to-detect-anal-intraepithelial-neoplasia-in-thai-men-who-have-sex-with-men-131233https://curecurrent.com/trials/a-repeat-dose-pharmacokinetic-pk-and-safety-study-of-gsk2838232-with-and-without-ritonavir-rtv-conducted-in-healthy-subj-131234https://curecurrent.com/trials/behavioral-and-biomedical-hiv-prevention-interventions-for-thai-men-who-have-sex-with-men-131235https://curecurrent.com/trials/single-dose-escalation-study-of-gsk2838232-in-healthy-subjects-131236https://curecurrent.com/trials/hearts-and-minds-in-hiv-131237https://curecurrent.com/trials/study-of-aeras-402-in-healthy-infants-131238https://curecurrent.com/trials/reducing-hiv-stigma-for-african-american-women-131239https://curecurrent.com/trials/fecal-microbiota-transplantation-in-hiv-131240https://curecurrent.com/trials/recruiting-african-american-fathers-sons-131241https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-immunologic-response-and-virologic-impact-of-ags-004-131242https://curecurrent.com/trials/once-a-day-use-of-lactobacillus-casei-shirota-on-hiv-infected-patients-infected-patients-131243https://curecurrent.com/trials/real-time-antiretroviral-therapy-adherence-intervention-in-uganda-131244https://curecurrent.com/trials/hope-harnessing-online-peer-education-using-online-social-networks-for-hiv-prevention-and-testing-131245https://curecurrent.com/trials/cohort-of-patients-naive-of-antiretroviral-treatment-at-enrollment-131246https://curecurrent.com/trials/male-circumcision-services-for-hiv-prevention-in-the-dominican-republic-131247https://curecurrent.com/trials/intervention-to-improve-hcv-treatment-uptake-and-adherence-in-hiv-hcv-coinfection-131248https://curecurrent.com/trials/facilitating-hiv-testing-among-young-adult-msm-through-social-networking-131249https://curecurrent.com/trials/facilitating-hiv-aids-and-hiv-testing-literacy-for-emergency-department-patients-131250https://curecurrent.com/trials/vaginal-practices-in-human-immunodeficiency-virus-hiv-positive-women-in-zambia-a-bio-behavioral-intervention-wash-2-131251https://curecurrent.com/trials/a-pilot-study-of-kaletra-and-intelence-tablets-in-naive-subjects-131252https://curecurrent.com/trials/international-latino-research-partnership-131253https://curecurrent.com/trials/study-of-the-48-week-virologic-and-immunologic-response-to-lopinavir-ritonavir-kaletra-in-hiv-positive-adult-patients-131254https://curecurrent.com/trials/drug-interaction-study-with-ribavirin-and-abacavir-in-male-subjects-with-hepatitis-c-who-have-failed-ribavirin-treatment-131255https://curecurrent.com/trials/nucleoside-switch-pilot-for-virologically-controlled-hiv-subjects-with-decreasing-cd4-cells-who-have-received-tdf-based-131256https://curecurrent.com/trials/incidence-of-h1n1v-influenza-like-illness-and-risk-factors-for-serious-influenza-forms-in-hiv-infected-patients-131257https://curecurrent.com/trials/enema-use-and-acceptability-in-hiv-negative-men-who-have-sex-with-men-131258https://curecurrent.com/trials/influenza-vaccine-in-hiv-131259https://curecurrent.com/trials/metabolomics-fingerprinting-and-metabolic-dynamics-after-hiv-infection-131260https://curecurrent.com/trials/hepatitis-b-virus-vertical-transmission-from-hiv-hbv-co-infected-women-131261https://curecurrent.com/trials/accuracy-of-portable-colposcopy-and-hpv-genotypes-among-hiv-women-131262https://curecurrent.com/trials/pediatric-hiv-disclosure-intervention-131263https://curecurrent.com/trials/decrease-of-neuropsychiatric-side-effects-after-switching-from-atripla-to-eviplera-131264https://curecurrent.com/trials/atomoxetine-for-ats-and-opioid-dependence-during-buprenorphine-maintenance-treatment-in-malaysia-131265https://curecurrent.com/trials/evaluate-tolerability-of-a-recombinant-dna-hiv-1-vaccine-in-healthy-adults-131266https://curecurrent.com/trials/evaluate-tolerability-of-a-multi-envelope-prime-boost-hiv-vaccine-in-healthy-adults-131267https://curecurrent.com/trials/conditional-cash-transfers-to-increase-uptake-of-and-retention-of-pmtct-services-131268https://curecurrent.com/trials/expanded-hiv-care-in-opioid-substitution-treatment-ehost-trial-131269https://curecurrent.com/trials/safety-and-effect-on-hiv-transcription-of-vorinostat-in-patients-receiving-suppressive-combination-anti-retroviral-thera-131270https://curecurrent.com/trials/victim-impact-modules-for-jail-inmates-131271https://curecurrent.com/trials/first-event-of-infection-by-hiv-1-of-uterine-vaginal-tissue-131272https://curecurrent.com/trials/quality-of-life-of-hiv-infected-participants-switched-to-raltegravir-versus-other-antiretroviral-regimens-mk-0518-266-131273https://curecurrent.com/trials/dual-rapid-hiv-syphilis-tests-in-zambia-131274https://curecurrent.com/trials/china-adherence-through-technology-study-131275https://curecurrent.com/trials/hepatitis-b-vaccination-in-hiv-infected-adults-with-low-cd4-cell-counts-131276https://curecurrent.com/trials/linkage-and-retention-a-randomized-trial-to-optimize-hiv-tb-care-in-south-africa-131277https://curecurrent.com/trials/hepatitis-b-vaccination-in-hiv-infected-adults-131278https://curecurrent.com/trials/yoga-intervention-for-substance-use-and-art-adherence-in-community-reentry-131279https://curecurrent.com/trials/improving-antiretroviral-medication-adherence-among-hiv-infected-youth-131280https://curecurrent.com/trials/pre-exposure-prophylaxis-in-ymsm-131281https://curecurrent.com/trials/vitamin-d-supplements-for-hiv-positive-patients-on-cart-131282https://curecurrent.com/trials/food-effect-study-with-bms-955176-131283https://curecurrent.com/trials/improving-antiretroviral-medication-adherence-among-hiv-infected-youth-phase-i-131284https://curecurrent.com/trials/methemoglobinemia-in-young-patients-with-hematologic-cancer-or-aplastic-anemia-treated-with-dapsone-131285https://curecurrent.com/trials/likely-use-of-prep-for-african-american-ymsm-131286https://curecurrent.com/trials/improving-drug-adherence-among-adolescents-in-uganda-using-sms-reminders-131287https://curecurrent.com/trials/sms-as-an-incentive-to-adhere-sita-an-intervention-communicating-social-norms-by-sms-to-improve-arv-adherence-131288https://curecurrent.com/trials/pain-and-sensory-changes-assessment-in-hiv-patients-131289https://curecurrent.com/trials/improving-immunogenicity-of-influenza-vaccine-in-hiv-infected-individuals-131290https://curecurrent.com/trials/antiviral-responses-to-nnrti-based-vs-pi-based-arv-therapy-in-hiv-infected-infants-who-have-or-have-not-received-single-131291https://curecurrent.com/trials/adherence-connection-for-counseling-education-and-support-131292https://curecurrent.com/trials/treatment-of-acute-hiv-infection-with-quad-fixed-dose-combination-fdc-tablet-131293https://curecurrent.com/trials/open-label-trial-of-peg-ifn-rbv-tvr-vs-peg-ifn-rbv-alone-in-tx-of-hcv-1-in-hiv-1-co-infected-patients-chat-131294https://curecurrent.com/trials/treatment-advocacy-intervention-for-hiv-positive-african-americans-131295https://curecurrent.com/trials/assisted-partner-notification-to-augment-hiv-treatment-and-prevention-in-kenya-131296https://curecurrent.com/trials/a-phase-2b-safety-and-efficacy-study-of-boceprevir-in-patients-coinfected-with-hiv-and-hepatitis-c-p05411-am4-131297https://curecurrent.com/trials/an-expanded-access-protocol-for-subjects-who-have-completed-clinical-studies-involving-maraviroc-131298https://curecurrent.com/trials/treatment-of-adult-onset-immunodeficiency-with-bortezomib-131299https://curecurrent.com/trials/efficacy-and-safety-of-pegintron-plus-ribavirin-for-treatment-of-chronic-hepatitis-c-in-hiv-infected-subjects-study-p044-131300https://curecurrent.com/trials/jamii-bora-a-home-based-couples-intervention-131301https://curecurrent.com/trials/multi-component-hiv-intervention-packages-for-chinese-men-who-have-sex-with-men-test-link-and-care-tlc-131302https://curecurrent.com/trials/a-rct-of-prednisone-as-adjunctive-therapy-for-hospitalized-patients-with-pulmonary-tb-and-hiv-co-infection-131303https://curecurrent.com/trials/effects-of-treatment-with-aprepitant-emend-in-hiv-infected-individuals-131304https://curecurrent.com/trials/observational-study-of-fat-loss-in-hiv-infected-adults-taking-nucleoside-reverse-transcriptase-inhibitors-nrtis-131305https://curecurrent.com/trials/comparison-of-three-hepatitis-b-vaccination-regimens-in-hiv-positive-youth-131306https://curecurrent.com/trials/effectiveness-of-two-hepatitis-b-vaccines-in-hiv-negative-youths-131307https://curecurrent.com/trials/preservation-and-expansion-of-t-cell-subsets-following-haart-de-intensification-to-atazanavir-ritonavir-atv-r-131308https://curecurrent.com/trials/performance-evaluation-of-the-bio-rad-geenius-hiv1-2-supplemental-assay-131309https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-boceprevir-and-telaprevir-on-dolutegravir-pharmacokinetics-in-healthy-adult-subjects-i-131310https://curecurrent.com/trials/dose-escalation-study-to-evaluate-the-safety-and-immunogenicity-of-mtbvac-vaccine-in-comparison-with-bcg-vaccine-131311https://curecurrent.com/trials/combination-of-insulin-sensitizer-and-leptin-as-treatment-for-the-haart-induced-metabolic-syndrome-131312https://curecurrent.com/trials/minority-aids-initiative-retention-and-re-engagement-project-131313https://curecurrent.com/trials/maraviroc-intensification-and-peripheral-blood-monocyte-hiv-dna-levels-131314https://curecurrent.com/trials/mk0518-in-the-treatment-of-hiv-infected-patients-switched-from-a-protease-inhibitor-regimen-0518-032-terminated-131315https://curecurrent.com/trials/a-study-to-determine-the-safety-and-efficacy-of-once-daily-raltegravir-compared-to-twice-daily-raltegravir-mk-0518-071-131316https://curecurrent.com/trials/mk0518-in-the-treatment-of-hiv-infected-patients-switched-from-a-protease-inhibitor-regimen-0518-033-terminated-131317https://curecurrent.com/trials/safety-and-immunological-response-of-a-boosting-dose-of-mva-b-in-healthy-volunteers-after-4-years-of-receiving-mva-b-131318https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-antiretroviral-activity-of-mk-0518-versus-efavirenz-in-treatment-naive-hiv-infected-p-131319https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-raltegravir-mk0518-in-hiv-infected-patients-failing-current-antiretrovira-131320https://curecurrent.com/trials/a-study-of-raltegravir-in-a-diverse-cohort-of-hiv-infected-patients-0518-055-131321https://curecurrent.com/trials/a-pharmacokinetic-study-to-evaluate-the-effect-of-antacids-on-raltegravir-mk-0518-in-hiv-infected-participants-mk-0518-2-131322https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-famotidine-and-omeprazole-on-mk0518-raltegravir-pharmacokinetics-in-human-immunodefici-131323https://curecurrent.com/trials/effects-of-newly-initiated-quad-therapy-on-aortic-coronary-inflammation-in-art-na-ve-infected-patients-131324https://curecurrent.com/trials/vitamin-d-supplementation-in-hiv-131325https://curecurrent.com/trials/study-of-the-preliminary-effect-of-tevaw-a-program-to-address-intimate-partner-violence-in-northern-tanzania-131326https://curecurrent.com/trials/individualized-triple-therapy-using-boceprevir-in-hiv-positive-patients-with-hepatitis-c-131327https://curecurrent.com/trials/early-versus-delayed-bcg-vaccination-of-hiv-exposed-infants-131328https://curecurrent.com/trials/hiv-and-kidney-function-study-131329https://curecurrent.com/trials/home-visiting-for-ovc-in-tshwane-townships-of-south-africa-131330https://curecurrent.com/trials/hiv-aids-orphaned-and-vulnerable-children-public-health-evaluation-131331https://curecurrent.com/trials/relationship-of-tenofovir-with-hiv-1-suppression-in-ex-vivo-tissue-in-adolescents-131332https://curecurrent.com/trials/treatment-options-for-protease-inhibitor-exposed-children-131333https://curecurrent.com/trials/phase-iii-peg-intron-in-hiv-infected-patients-study-p00738-131334https://curecurrent.com/trials/pro-140-for-human-immunodeficiency-virus-infection-131335https://curecurrent.com/trials/detraining-in-people-living-with-hiv-aids-131336https://curecurrent.com/trials/sustiva-levels-with-use-of-a-gel-capsule-131337https://curecurrent.com/trials/engaging-hiv-patients-in-primary-care-by-promoting-acceptance-131338https://curecurrent.com/trials/positive-pregnancy-program-131339https://curecurrent.com/trials/patient-centered-disclosure-intervention-for-hiv-infected-children-131340https://curecurrent.com/trials/vacc-4x-lenalidomide-vs-vacc-4x-placebo-in-hiv-1-infected-subjects-on-antiretroviral-therapy-art-131341https://curecurrent.com/trials/48-week-study-of-gw433908-and-ritonavir-or-gw433908-alone-twice-daily-in-pediatric-patients-with-hiv-infection-131342https://curecurrent.com/trials/a-pilot-study-of-adjunctive-aspirin-for-the-treatment-of-hiv-negative-adults-with-tuberculous-meningitis-131343https://curecurrent.com/trials/empowerment-intervention-for-young-women-phase-i-131344https://curecurrent.com/trials/re-boosting-of-hiv-1-infected-subjects-with-vacc-4x-131345https://curecurrent.com/trials/intervention-for-newly-diagnosed-youth-with-hiv-131346https://curecurrent.com/trials/engaging-care-for-hiv-infected-adolescent-females-131347https://curecurrent.com/trials/integrated-treatment-of-marijuana-abuse-for-hiv-youth-131348https://curecurrent.com/trials/treatment-plan-to-decrease-drug-exposure-in-hiv-infected-adolescents-131349https://curecurrent.com/trials/a-trial-of-zinc-and-micronutrients-in-tanzanian-children-131350https://curecurrent.com/trials/the-effect-of-pas-on-the-pharmacokinetics-of-tenofovir-in-healthy-subjects-131351https://curecurrent.com/trials/egrifta-replacement-and-sleep-disordered-breathing-131352https://curecurrent.com/trials/c2p-phase-iii-mpowerment-and-community-promise-131353https://curecurrent.com/trials/pro-140-for-human-immunodeficiency-virus-131354https://curecurrent.com/trials/raltegravir-as-early-therapy-in-african-americans-living-with-hiv-study-131355https://curecurrent.com/trials/promoting-exclusive-breastfeeding-among-hiv-infected-women-in-a-pmtct-program-131356https://curecurrent.com/trials/immune-activation-and-drug-absorption-in-hiv-infected-patients-131357https://curecurrent.com/trials/a-clinical-study-of-an-investigational-regimen-including-marketed-hiv-drugs-in-hiv-1-pediatric-subjects-ages-2-18-years-131358https://curecurrent.com/trials/preventative-misconception-intervention-131359https://curecurrent.com/trials/traditional-complementary-and-alternative-medicine-cam-therapy-in-the-treatment-of-hiv-aids-131360https://curecurrent.com/trials/chronic-hepatitis-intervention-project-for-drug-users-131361https://curecurrent.com/trials/metabolic-abnormalities-in-hiv-infected-and-uninfected-young-women-131362https://curecurrent.com/trials/simplified-consent-for-hiv-vaccine-trials-131363https://curecurrent.com/trials/family-based-hiv-prevention-for-adolescent-girls-131364https://curecurrent.com/trials/4-day-a-week-treatment-plan-for-hiv-infected-adolescents-131365https://curecurrent.com/trials/metabolic-abnormalities-hiv-infected-and-uninfected-males-131366https://curecurrent.com/trials/a-novel-method-to-determine-hiv-incidence-among-youth-131367https://curecurrent.com/trials/typology-of-adherence-in-adolescents-phase-ii-131368https://curecurrent.com/trials/safety-and-efficacy-of-romidepsin-and-the-therapeutic-vaccine-vacc-4x-for-reduction-of-the-latent-hiv-1-reservoir-131369https://curecurrent.com/trials/connect-to-protect-partnerships-for-youth-prevention-interventions-phase-ii-131370https://curecurrent.com/trials/phases-provision-of-hiv-treatment-at-atn-sites-an-evaluation-for-stakeholders-131371https://curecurrent.com/trials/phase-ii-study-of-the-efficacy-of-peptide-t-in-hiv-positive-individuals-with-cognitive-impairment-131372https://curecurrent.com/trials/hiv-treatment-readiness-measure-htrm-validation-131373https://curecurrent.com/trials/connect-to-protect-c2p-building-a-community-based-infrastructure-for-hiv-prevention-131374https://curecurrent.com/trials/transitioning-hiv-adolescents-to-adult-care-exploring-adolescent-and-adult-medicine-clinics-role-in-the-process-131375https://curecurrent.com/trials/treatment-de-intensification-and-residual-hiv-1-in-youth-131376https://curecurrent.com/trials/trial-of-probiotics-to-lower-microbial-translocation-and-immune-activation-in-hiv-infected-adolescents-131377https://curecurrent.com/trials/feasibility-of-using-a-structured-daily-diary-131378https://curecurrent.com/trials/neurocognitive-assessment-in-youth-initiating-haart-131379https://curecurrent.com/trials/pk-of-once-daily-art-containing-tenofovir-and-atazanavir-ritonavir-131380https://curecurrent.com/trials/psychosocial-needs-of-ymsm-131381https://curecurrent.com/trials/evaluation-of-genetic-markers-as-explanations-for-the-observed-differences-in-disease-progression-in-hiv-youth-131382https://curecurrent.com/trials/impact-of-anti-hiv-treatment-on-labor-productivity-and-costs-in-south-africa-131383https://curecurrent.com/trials/enhancement-of-connect-to-protect-c2p-131384https://curecurrent.com/trials/ptsd-and-risk-behavior-in-hiv-positive-female-adolescents-131385https://curecurrent.com/trials/microbicides-acceptability-among-sexually-active-young-women-131386https://curecurrent.com/trials/linkage-to-care-part-i-131387https://curecurrent.com/trials/treatment-for-depression-among-hiv-infected-youth-131388https://curecurrent.com/trials/intervention-for-hiv-positive-black-young-men-who-have-sex-with-men-ymsm-131389https://curecurrent.com/trials/factors-affecting-prep-adherence-131390https://curecurrent.com/trials/hepatitis-b-vaccine-genetics-a-substudy-of-atn-024-and-atn-025-131391https://curecurrent.com/trials/c2p-with-venues-connect-to-protect-partnerships-for-youth-prevention-interventions-131392https://curecurrent.com/trials/development-of-an-empowerment-intervention-for-young-women-living-with-hiv-131393https://curecurrent.com/trials/friendship-based-hiv-sti-sexually-transmitted-infections-intervention-for-african-american-females-131394https://curecurrent.com/trials/c2p-mobilization-intervention-pilot-131395https://curecurrent.com/trials/linkage-to-care-part-ii-131396https://curecurrent.com/trials/id-and-testing-via-friendship-networks-131397https://curecurrent.com/trials/intervention-development-for-newly-diagnosed-youth-with-hiv-131398https://curecurrent.com/trials/development-of-a-life-skills-intervention-for-young-adolescents-perinatally-infected-with-hiv-and-their-caregivers-131399https://curecurrent.com/trials/cdc-atn-linkage-evaluation-131400https://curecurrent.com/trials/correlates-of-oral-human-papillomavirus-infection-in-adolescents-and-young-adults-with-behaviorally-acquired-hiv-131401https://curecurrent.com/trials/managerial-database-ii-131402https://curecurrent.com/trials/immunologic-memory-supp-of-atn-024-131403https://curecurrent.com/trials/identifying-undiagnosed-asymptomatic-hiv-infection-in-hispanic-latino-adolescents-and-young-adults-131404https://curecurrent.com/trials/self-consent-for-prep-perspectives-131405https://curecurrent.com/trials/assessing-the-engagement-of-transgender-and-other-gender-minority-youth-across-the-hiv-continuum-of-care-131406https://curecurrent.com/trials/vitamin-d-reabsorption-in-adolescents-and-young-adults-with-hiv-infection-131407https://curecurrent.com/trials/life-skills-intervention-for-adolescents-perinatally-infected-with-hiv-131408https://curecurrent.com/trials/managerial-database-ii-131409https://curecurrent.com/trials/project-accept-engaging-newly-diagnosed-hiv-youth-in-care-131410https://curecurrent.com/trials/clinician-attitudes-and-behaviors-regarding-use-of-pre-exposure-prophylaxis-prep-for-primary-hiv-prevention-131411https://curecurrent.com/trials/cell-phone-reminders-intervention-131412https://curecurrent.com/trials/evaluation-of-three-strategies-of-second-line-antiretroviral-treatment-in-africa-dakar-bobo-dioulasso-yaound-131413https://curecurrent.com/trials/immunogenicity-study-of-vacc-4x-versus-placebo-in-patients-infected-with-hiv-131414https://curecurrent.com/trials/collection-of-samples-from-hiv-1-infected-individuals-for-evaluation-of-the-aptima-hiv-1-assay-131415https://curecurrent.com/trials/hiv-risk-and-prevention-in-women-131416https://curecurrent.com/trials/safety-study-of-isentress-truvada-in-post-exposure-treatment-of-hiv-infection-131417https://curecurrent.com/trials/community-health-workers-and-prevention-of-mother-to-child-hiv-transmission-in-tanzania-131418https://curecurrent.com/trials/comparison-of-two-combinations-in-antiretroviral-post-exposure-prophylaxis-for-hiv-1-tenofovir-emtricitabine-truvada-lop-131419https://curecurrent.com/trials/a-study-of-indinavir-plus-ritonavir-plus-two-nrtis-vs-nelfinavir-plus-two-nrtis-in-hiv-positive-patients-0639-112-comple-131420https://curecurrent.com/trials/third-line-antiretroviral-treatment-optimization-in-sub-saharan-africa-131421https://curecurrent.com/trials/the-impact-of-structured-exercise-on-brain-health-in-hiv-positive-individuals-131422https://curecurrent.com/trials/study-to-evaluate-darunavir-ritonavir-lamivudine-versus-continuing-with-darunavir-ritonavir-tenofovir-emtricitabine-or-a-131423https://curecurrent.com/trials/formative-research-for-an-hiv-videogame-for-young-black-women-131424https://curecurrent.com/trials/intervention-to-encourage-hiv-testing-and-counseling-among-adolescents-131425https://curecurrent.com/trials/care-corrections-technology-for-jail-hiv-hcv-testing-linkage-and-care-tlc-131426https://curecurrent.com/trials/spurring-innovation-to-promote-hiv-testing-an-rct-evaluating-crowdsourcing-131427https://curecurrent.com/trials/pediatric-decentralization-of-art-in-south-africa-131428https://curecurrent.com/trials/self-and-family-management-intervention-in-hiv-chinese-women-131429https://curecurrent.com/trials/accuracy-evaluation-of-the-bd-facs-presto-system-131430https://curecurrent.com/trials/exploring-the-impact-of-hiv-and-art-on-knowledge-attitudes-and-practices-in-reproductive-health-in-lilongwe-malawi-131431https://curecurrent.com/trials/text-messaging-intervention-to-improve-retention-in-care-and-virologic-suppression-in-an-urban-hiv-infected-population-131432https://curecurrent.com/trials/dapivirine-gel-rectal-safety-and-pk-study-131433https://curecurrent.com/trials/engage4health-a-combination-intervention-strategy-for-linkage-and-retention-in-mozambique-131434https://curecurrent.com/trials/dose-adaptation-to-offset-the-interaction-between-ticagrelor-and-ritonavir-by-population-based-pk-modeling-131435https://curecurrent.com/trials/a-trial-of-radiofrequency-ablation-for-anal-intraepithelial-neoplasia-using-the-halo-ablation-system-131436https://curecurrent.com/trials/rosiglitazone-effect-on-mitochondria-and-lipoatrophy-131437https://curecurrent.com/trials/financial-incentives-to-increase-pediatric-hiv-testing-pilot-study-fit-pilot-131438https://curecurrent.com/trials/effect-of-cobicistat-versus-ritonavir-boosting-on-the-brain-permeation-of-darunavir-in-hiv-infected-individuals-131439https://curecurrent.com/trials/immunological-memory-induced-by-the-13valent-pneumococcal-conjugate-pcv13-and-23valent-plain-polysaccharide-vaccine-ppv2-131440https://curecurrent.com/trials/a-trial-of-observed-long-acting-anti-hiv-treatment-with-a-monoclonal-ccr5-antibody-pro-140-as-an-adjunct-to-a-new-optimi-131441https://curecurrent.com/trials/tuberculosis-recurrence-upon-treatment-with-highly-active-antiretroviral-therapy-131442https://curecurrent.com/trials/welteloaktree-text-messaging-to-support-patients-with-hiv-aids-in-british-columbia-131443https://curecurrent.com/trials/randomised-study-comparing-two-hiv-screening-strategies-131444https://curecurrent.com/trials/adherence-to-dolutegravir-and-outcome-131445https://curecurrent.com/trials/pilot-study-of-adding-raltegravir-mk-0518-to-antiretroviral-therapy-in-patients-with-low-level-viremia-131446https://curecurrent.com/trials/cognitive-based-compassion-training-cbct-for-people-living-with-hiv-plhiv-131447https://curecurrent.com/trials/statin-adjunct-therapy-among-art-treated-adults-in-sub-saharan-africa-atorvastatin-and-rosuvastatin-equivalence-trial-131448https://curecurrent.com/trials/hepatitis-b-virus-hbv-prevention-for-homeless-at-risk-for-hbv-hepatitis-c-virus-hcv-hiv-131449https://curecurrent.com/trials/viral-suppression-after-analytic-treatment-interruption-in-thai-patients-who-initiated-highly-active-antiretroviral-ther-131450https://curecurrent.com/trials/rilpivirine-in-virologically-suppressed-adolescents-131451https://curecurrent.com/trials/systems-analysis-and-improvement-to-optimize-pmtct-131452https://curecurrent.com/trials/the-effect-of-malaria-on-disease-progression-of-hiv-aids-131453https://curecurrent.com/trials/a-study-for-safety-and-immunogenicity-of-bcg-and-aeras-404-in-hiv-negative-tb-negative-bcg-naive-adults-131454https://curecurrent.com/trials/ral-atv-r-in-comparison-with-tdf-ftc-or-3tc-atv-r-in-hiv-infected-patients-131455https://curecurrent.com/trials/active-search-for-pediatric-hiv-aids-aspa-131456https://curecurrent.com/trials/computer-based-intervention-in-hiv-positive-young-adults-131457https://curecurrent.com/trials/safety-and-efficacy-study-of-ags-004-during-analytical-treatment-interruption-131458https://curecurrent.com/trials/randomized-controlled-trial-of-shang-ring-male-children-circumcision-comparison-between-flip-and-no-flip-technique-131459https://curecurrent.com/trials/planning-for-success-131460https://curecurrent.com/trials/network-supported-engagement-in-hiv-care-131461https://curecurrent.com/trials/reduction-of-drug-use-and-hiv-risk-among-out-of-treatment-methamphetamine-users-131462https://curecurrent.com/trials/gsk1349572-drug-interaction-study-with-fosamprenavir-ritonavir-131463https://curecurrent.com/trials/art-drug-dosage-adjustment-in-hiv-infected-population-131464https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-bms-955176-on-pharmacokinetics-of-dolutegravir-and-the-effect-of-dolutegravir-on-the-p-131465https://curecurrent.com/trials/use-of-muscle-spectroscopy-to-evaluate-mitochondrial-dysfunction-in-hiv-infected-patients-131466https://curecurrent.com/trials/reducing-hiv-in-adolescents-131467https://curecurrent.com/trials/relative-bio-availability-study-of-dolutegravir-and-lamivudine-fixed-dose-combinations-131468https://curecurrent.com/trials/single-and-repeated-dose-escalation-study-of-gsk2838232-131469https://curecurrent.com/trials/voluma-filler-agent-for-the-treatment-of-hiv-associated-facial-lipoatrophy-131470https://curecurrent.com/trials/the-tractor-tracking-and-tracing-operations-research-study-zimbabwe-131471https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-high-fat-meal-on-cabotegravir-131472https://curecurrent.com/trials/hiv-std-safer-sex-skills-groups-for-men-in-drug-treatment-programs-1-131473https://curecurrent.com/trials/molecular-diversity-of-hiv-1-group-o-strains-and-treatment-management-in-cameroon-131474https://curecurrent.com/trials/hiv-and-hcv-intervention-in-drug-treatment-settings-1-131475https://curecurrent.com/trials/hiv-std-safer-sex-skills-groups-for-women-in-drug-treatment-programs-1-131476https://curecurrent.com/trials/influence-of-chloroquine-on-hiv-viral-load-among-pregnant-women-in-uganda-131477https://curecurrent.com/trials/motivation-and-patch-treatment-for-hiv-positive-smokers-131478https://curecurrent.com/trials/enhancing-uptake-of-family-planning-services-by-hiv-infected-women-attending-the-pmtct-program-131479https://curecurrent.com/trials/positive-choice-prevention-for-positive-health-131480https://curecurrent.com/trials/cognitive-behavioral-stress-management-for-hiv-drug-abusers-131481https://curecurrent.com/trials/an-hepatitis-b-vaccine-model-for-hiv-vaccine-trials-in-drug-users-131482https://curecurrent.com/trials/comparing-the-effects-of-smoked-and-oral-marijuana-in-individuals-with-hiv-aids-131483https://curecurrent.com/trials/the-aim-of-this-study-is-to-determine-the-effectiveness-of-a-motivational-enhancement-intervention-in-reducing-risk-beha-131484https://curecurrent.com/trials/physician-focused-intervention-to-improve-adherence-with-hiv-antiretrovirals-131485https://curecurrent.com/trials/study-to-reduce-intravenous-exposures-strive-131486https://curecurrent.com/trials/multi-level-hiv-prevention-for-pregnant-drug-abusers-131487https://curecurrent.com/trials/intervention-for-sustained-testing-and-retention-among-hiv-infected-patients-131488https://curecurrent.com/trials/antibodies-and-memory-cells-role-after-different-pneumococcal-vaccines-in-hiv-adults-131489https://curecurrent.com/trials/comparing-the-effectiveness-of-two-alcohol-adherence-interventions-for-hiv-youth-131490https://curecurrent.com/trials/study-of-pre-clearance-of-latent-tuberculosis-infection-and-bcg-revaccination-131491https://curecurrent.com/trials/pre-exposure-option-for-reducing-hiv-in-the-uk-proud-131492https://curecurrent.com/trials/effects-of-aerobic-exercise-on-cd4-count-viral-load-selected-psycho-social-trait-131493https://curecurrent.com/trials/a-phase-iiib-study-of-the-safety-efficacy-and-tolerability-of-switching-to-a-fixed-dose-combination-of-abacavir-dolutegr-131494https://curecurrent.com/trials/hiv-prevention-for-plhiv-evaluation-of-an-intervention-toolkit-for-hiv-care-treatment-settings-131495https://curecurrent.com/trials/hiv-translating-initiatives-for-depression-into-effective-solutions-131496https://curecurrent.com/trials/a-roll-over-observational-study-for-the-extended-follow-up-of-the-volunteers-of-the-iss-t-003-trial-131497https://curecurrent.com/trials/a-phase-1-open-label-dose-escalation-study-of-the-safety-pharmacokinetics-and-antiretroviral-activity-of-3bnc117-131498https://curecurrent.com/trials/addition-of-raltegravir-to-established-antiretroviral-suppressive-therapy-131499https://curecurrent.com/trials/behavioral-activation-armodafinil-to-treat-fatigue-in-hiv-aids-131500https://curecurrent.com/trials/hiv-with-innovative-group-antenatal-care-in-two-african-countries-131501https://curecurrent.com/trials/extending-hiv-care-beyond-the-rural-health-center-131502https://curecurrent.com/trials/prevalence-of-liver-fibrosis-and-progression-of-liver-fibrosis-131503https://curecurrent.com/trials/trichomonas-vaginalis-recurrence-among-hiv-women-131504https://curecurrent.com/trials/brief-intervention-to-reduce-stds-in-er-drug-users-131505https://curecurrent.com/trials/dna-clearance-of-uncomplicated-trichomonas-vaginalis-infections-in-hiv-negative-women-131506https://curecurrent.com/trials/effects-of-interferon-gamma-on-cavitary-pulmonary-tuberculosis-in-the-lungs-131507https://curecurrent.com/trials/evaluation-of-the-cellular-pharmacology-of-tenofovir-and-emtricitabine-according-to-hiv-infection-status-131508https://curecurrent.com/trials/a-study-of-cytotoxic-t-lymphocyte-ctl-therapy-in-hiv-infected-patients-131509https://curecurrent.com/trials/a-randomized-trial-of-l-735-524-an-inhibitor-of-the-hiv-protease-enzyme-and-interleukin-2-in-persons-infected-with-hiv-n-131510https://curecurrent.com/trials/handheld-computers-to-improve-adherence-to-anti-hiv-drug-regimens-131511https://curecurrent.com/trials/daily-tenofovir-df-to-prevent-hiv-infection-among-sex-workers-in-cambodia-131512https://curecurrent.com/trials/therapeutic-hiv-vaccine-and-interleukin-2-to-increase-the-immune-system-s-response-to-hiv-131513https://curecurrent.com/trials/controlled-clinical-trial-of-antiviral-cytotoxic-t-lymphocyte-ctl-infusion-following-combination-antiretroviral-drug-the-131514https://curecurrent.com/trials/treatment-of-chronic-cryptosporidiosis-in-aids-patients-131515https://curecurrent.com/trials/vitamin-a-to-reduce-hiv-in-vaginal-secretions-and-prevent-viral-transmission-131516https://curecurrent.com/trials/a-pilot-study-of-immunization-with-hiv-1-antigen-pulsed-allogenic-dendritic-cells-in-hiv-infected-asymptomatic-patients-131517https://curecurrent.com/trials/safety-and-efficacy-of-cobicistat-boosted-darunavir-in-hiv-infected-adults-131518https://curecurrent.com/trials/interleukin-12-il-12-for-the-treatment-of-cryptosporidiosis-in-aids-patients-131519https://curecurrent.com/trials/pilot-study-evaluating-the-use-of-simultaneous-hbv-hcv-and-hiv-rapid-tests-131520https://curecurrent.com/trials/pioglitazone-to-treat-fatty-liver-in-patients-with-hiv-and-hepatitis-c-infections-131521https://curecurrent.com/trials/pk-of-efavirenz-lopinavir-nano-formulations-in-healthy-volunteers-131522https://curecurrent.com/trials/a-post-marketing-survey-study-to-evaluate-the-safety-and-effectiveness-of-prezista-131523https://curecurrent.com/trials/tipranavir-in-patients-with-progressive-systemic-hiv-1-disease-who-have-failed-or-are-intolerant-to-currently-approved-t-131524https://curecurrent.com/trials/tipranavir-expanded-access-program-eap-in-pi-experienced-patients-with-hiv-1-infection-131525https://curecurrent.com/trials/folinic-acid-supplementation-and-therapy-131526https://curecurrent.com/trials/the-prenaps-study-fi-nutrition-and-psychosocial-health-outcomes-at-gulu-regional-referral-hospital-131527https://curecurrent.com/trials/an-open-label-safety-study-of-tipranavir-co-administered-with-low-dose-ritonavir-in-patients-with-advanced-hiv-1-infecti-131528https://curecurrent.com/trials/interferon-alfa-sensitivity-in-hiv-hcv-persons-before-and-after-hiv-meds-131529https://curecurrent.com/trials/trial-of-collaborative-depression-care-management-for-hiv-patients-131530https://curecurrent.com/trials/immediate-versus-deferred-antiretroviral-therapy-in-hiv-infected-patients-presenting-with-acute-aids-defining-events-131531https://curecurrent.com/trials/mothers-living-with-hiv-and-their-adolescent-children-131532https://curecurrent.com/trials/an-hiv-intervention-for-black-men-at-risk-the-enhanced-sexual-health-intervention-for-men-es-him-131533https://curecurrent.com/trials/a-parenting-and-self-care-intervention-for-hiv-infected-mothers-131534https://curecurrent.com/trials/cognitive-remediation-for-hiv-associated-neurocognitive-dysfunction-131535https://curecurrent.com/trials/fluoride-metabolism-bone-remodelling-and-mineral-density-in-hiv-patients-treated-with-tenofovir-emtricitabine-131536https://curecurrent.com/trials/acceptability-feasibility-of-hiv-testing-by-elisa-or-rapid-test-to-adult-patients-in-paris-france-131537https://curecurrent.com/trials/trial-of-the-safety-and-immunogenicity-of-an-oral-replicating-ad26-vectored-hiv-1-vaccine-131538https://curecurrent.com/trials/aims-study-improving-hiv-treatment-adherence-131539https://curecurrent.com/trials/treatment-with-probiotics-saccharomyces-boulardii-and-its-role-in-bacterial-translocation-and-immune-reconstitution-in-v-131540https://curecurrent.com/trials/cognition-metabolism-and-exercise-among-women-living-with-hiv-in-puerto-rico-131541https://curecurrent.com/trials/the-safety-and-immunogenicity-of-the-dna-gtu-vaccine-administered-to-hiv-infected-patients-on-art-vs-placebo-131542https://curecurrent.com/trials/prospective-study-of-lymphoproliferative-diseases-131543https://curecurrent.com/trials/a-study-of-hiv-in-newly-infected-individuals-131544https://curecurrent.com/trials/a-study-of-zidovudine-in-the-prevention-of-hiv-infection-in-individuals-exposed-to-the-virus-131545https://curecurrent.com/trials/phase-i-trial-of-an-intervention-to-increase-condom-use-by-hiv-discordant-couples-131546https://curecurrent.com/trials/an-observational-study-of-induction-therapy-with-fuzeon-enfuvirtide-in-combination-with-antiretroviral-drugs-in-patients-131547https://curecurrent.com/trials/optimizing-integrated-pmtct-services-in-rural-north-central-nigeria-131548https://curecurrent.com/trials/a-study-of-enfuvirtide-fuzeon-in-patients-with-advanced-human-immunodeficiency-virus-1-hiv-1-infection-131549https://curecurrent.com/trials/a-study-of-ritonavir-boosted-invirase-saquinavir-in-treatment-na-ve-hiv-1-infected-patients-131550https://curecurrent.com/trials/observational-study-on-predictors-of-response-to-invirase-saquinavir-treatment-in-treatment-na-ve-patients-with-hiv-infe-131551https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-once-daily-fuzeon-enfuvirtide-dosing-versus-the-currently-recommended-twice-131552https://curecurrent.com/trials/contingency-management-in-the-delivery-of-haart-to-drug-users-in-chennai-india-131553https://curecurrent.com/trials/qualite-study-a-study-of-fuzeon-enfuvirtide-in-treatment-experienced-patients-with-human-immunodeficiency-virus-1-hiv-1-131554https://curecurrent.com/trials/collection-of-blood-samples-from-smart-study-participants-for-future-genetic-studies-131555https://curecurrent.com/trials/compassionate-use-of-ibalizumab-for-the-treatment-of-hiv-infection-131556https://curecurrent.com/trials/hiv-eradication-through-cord-blood-transplantation-131557https://curecurrent.com/trials/the-effect-of-acyclovir-treatment-of-the-herpes-simplex-virus-hsv-infection-on-hiv-levels-in-the-blood-131558https://curecurrent.com/trials/a-test-of-behavioral-intervention-for-women-at-high-risk-for-hiv-infection-131559https://curecurrent.com/trials/a-treatment-ind-for-retrovir-brand-zidovudine-azt-therapy-of-pediatric-patients-with-hiv-disease-131560https://curecurrent.com/trials/pepi-tidp23-c104-is-a-first-in-human-study-with-a-single-dose-escalation-part-and-a-multiple-dosing-part-for-compounds-t-131561https://curecurrent.com/trials/adherence-health-outcome-differences-amongst-hiv-infected-patients-prescribed-haart-131562https://curecurrent.com/trials/effect-of-schistosomiasis-mansoni-on-hiv-susceptibility-and-female-genital-immunology-131563https://curecurrent.com/trials/a-randomized-controlled-trial-of-the-bruthas-project-131564https://curecurrent.com/trials/hcv-treatment-in-hiv-co-infected-patients-in-asia-131565https://curecurrent.com/trials/rapid-diagnostic-tests-and-clinical-laboratory-predictors-of-tropical-diseases-in-patients-with-persistent-fever-in-camb-131566https://curecurrent.com/trials/influence-of-pravastatin-on-carotid-artery-structure-and-function-in-hiv-infected-patients-under-antiretroviral-therapy-131567https://curecurrent.com/trials/the-spot-project-motivational-interviewing-in-conjunction-with-rapid-hiv-testing-131568https://curecurrent.com/trials/prevalence-of-cerebral-small-vessel-disease-in-hiv-infected-patients-131569https://curecurrent.com/trials/dvd-based-hiv-hcv-prevention-intervention-for-drug-involved-latino-criminal-justice-clients-131570https://curecurrent.com/trials/revealing-increased-axonal-loss-in-treated-hiv-patients-131571https://curecurrent.com/trials/neurocognitive-effects-and-tolerability-of-efavirenz-in-aging-hiv-infected-individuals-shac-neuro-study-131572https://curecurrent.com/trials/real-life-security-and-efficacy-of-daa-based-therapy-in-hcv-hiv-coinfected-patients-131573https://curecurrent.com/trials/ilink-incentives-for-linkage-to-art-study-a-mixed-methods-study-to-improve-linkage-to-hiv-care-131574https://curecurrent.com/trials/pilot-study-to-describe-immune-responses-of-healthy-women-following-immunization-with-varicella-zoster-virus-vaccine-131575https://curecurrent.com/trials/pre-exposure-prophylaxis-acceptability-readiness-assessments-for-toronto-gay-bisexual-and-other-men-who-have-sex-with-me-131576https://curecurrent.com/trials/adding-maraviroc-to-the-haart-regimen-of-well-controlled-hiv-infected-patients-131577https://curecurrent.com/trials/inhalation-nasal-corticosteroids-and-prevalence-of-hypothalamic-pituitary-adrenal-hpa-axis-suppression-in-human-immunode-131578https://curecurrent.com/trials/brazilian-hiv-sexually-transmitted-infection-sti-prevention-for-adolescents-with-mental-health-disorder-131579https://curecurrent.com/trials/prep-with-tdf-ftc-to-prevent-hiv-1-acquisition-in-young-msm-and-transgender-women-of-color-131580https://curecurrent.com/trials/the-effect-of-probiotics-on-microbial-translocation-and-inflammation-in-hiv-infected-patients-131581https://curecurrent.com/trials/same-day-hiv-testing-and-treatment-initiation-to-improve-retention-in-care-131582https://curecurrent.com/trials/a-controlled-study-of-the-safety-and-efficacy-of-lessertia-frutescens-in-hiv-infected-south-african-adults-131583https://curecurrent.com/trials/effects-of-pitavastatin-on-lipid-profiles-in-hiv-infected-patients-with-dyslipidemia-and-receiving-atazanavir-ritonavir-131584https://curecurrent.com/trials/intervention-targeting-substance-using-older-adults-with-hiv-131585https://curecurrent.com/trials/seek-test-treat-strategies-for-vietnamese-drug-users-a-randomized-controlled-trial-131586https://curecurrent.com/trials/heterosexual-hiv-transmission-study-hats-131587https://curecurrent.com/trials/pilot-simplification-study-to-lopinavir-ritonavir-800-200-mg-monotherapy-regimen-once-daily-131588https://curecurrent.com/trials/dolutegravir-interactions-with-artemisinin-based-combination-therapies-131589https://curecurrent.com/trials/integrated-mental-health-treatment-hiv-prevention-for-court-involved-youth-131590https://curecurrent.com/trials/rewarding-adherence-program-an-intervention-using-small-prizes-allocated-by-a-prize-drawing-to-increase-arv-adherence-131591https://curecurrent.com/trials/implementation-of-a-sexual-health-intervention-for-young-men-who-have-sex-with-men-msm-in-two-vietnamese-cities-131592https://curecurrent.com/trials/asha-hiv-health-promotion-intervention-in-india-131593https://curecurrent.com/trials/investigating-immunisation-strategies-of-dna-mva-and-cn54rgp140-adjuvanted-with-gla-af-to-maximise-antibody-responses-131594https://curecurrent.com/trials/tenofovir-pharmacology-in-older-hiv-infected-individuals-131595https://curecurrent.com/trials/drug-interaction-study-of-lopinavir-ritonavir-and-gemfibrozil-131596https://curecurrent.com/trials/immunogenicity-of-fluzone-hd-a-high-dose-influenza-vaccine-in-children-with-cancer-or-hiv-131597https://curecurrent.com/trials/raltegravir-switch-study-to-reduce-liver-fibrosis-progression-in-hiv-hepatitis-c-co-infection-131598https://curecurrent.com/trials/randomized-control-trial-of-family-based-hiv-prevention-for-latinos-131599https://curecurrent.com/trials/contingency-management-for-methamphetamine-abstinence-and-hiv-post-exposure-prophylaxis-in-men-who-have-sex-with-men-131600https://curecurrent.com/trials/tmc114-c202-a-study-of-safety-efficacy-and-tolerability-of-tmc114-and-low-dose-ritonavir-in-hiv-1-infected-patients-131601https://curecurrent.com/trials/a-phase-iv-study-of-bms-232632-in-hiv-patients-with-metabolic-syndrome-131602https://curecurrent.com/trials/differences-in-malaria-infection-levels-in-hiv-infected-infants-and-children-receiving-pi-and-nnrti-based-haart-131603https://curecurrent.com/trials/knowledge-attitudes-beliefs-and-practices-relative-to-hiv-among-sex-workers-in-french-guiana-131604https://curecurrent.com/trials/knowledge-attitudes-beliefs-and-practices-regarding-hiv-in-populations-living-on-the-maroni-river-131605https://curecurrent.com/trials/knowledge-attitudes-beliefs-and-practices-regarding-hiv-among-teenagers-in-french-guiana-131606https://curecurrent.com/trials/lung-hiv-microbiome-project-michigan-site-131607https://curecurrent.com/trials/sustained-virological-suppression-and-improvement-of-adverse-events-of-switching-to-raltegravir-study-131608https://curecurrent.com/trials/study-of-a-combination-pill-with-gs-7977-and-gs-5885-for-hepatitis-c-in-people-with-hiv-131609https://curecurrent.com/trials/predicting-treatment-and-care-difficulties-among-hiv-infected-patients-131610https://curecurrent.com/trials/changes-in-lipids-and-lipoproteins-in-hiv-infected-women-after-switch-from-protease-inhibitor-to-raltegravir-131611https://curecurrent.com/trials/fosamprenavir-expanded-access-131612https://curecurrent.com/trials/peer-groups-for-healthy-pregnancy-hiv-prevention-for-young-malawian-women-131613https://curecurrent.com/trials/boston-alcohol-research-collaboration-on-hiv-aids-arch-cohort-131614https://curecurrent.com/trials/use-of-concomitant-medications-in-hiv-1-infected-patients-in-a-large-community-practice-in-sydney-australia-131615https://curecurrent.com/trials/safety-and-immunogenicity-of-aeras-402-in-hiv-infected-bacillus-calmette-guerin-bcg-vaccinated-adults-131616https://curecurrent.com/trials/retrospective-study-of-the-survival-of-patients-suffering-from-hiv-related-progressive-multifocal-leukoencephalopathy-131617https://curecurrent.com/trials/methadone-maintenance-hiv-risk-in-ukraine-131618https://curecurrent.com/trials/feasibility-of-an-ingestible-sensor-system-to-measure-prep-adherence-in-ymsm-131619https://curecurrent.com/trials/pegasys-long-term-anti-fibrotic-effect-co-infection-trial-perfect-131620https://curecurrent.com/trials/exploratory-pharmacodynamic-study-of-tenofovir-based-products-131621https://curecurrent.com/trials/hiv-internet-sex-study-internet-based-sti-hiv-prevention-for-hiv-internet-users-131622https://curecurrent.com/trials/development-of-adherence-biomarkers-for-multiple-microbicide-and-multipurpose-prevention-technology-mpt-dosage-forms-131623https://curecurrent.com/trials/longitudinal-studies-of-hiv-associated-lung-infections-and-complications-lung-hiv-131624https://curecurrent.com/trials/redistribution-of-fat-and-metabolic-change-in-hiv-infection-protocol-2-fram-fat-2-131625https://curecurrent.com/trials/a-computer-based-parent-adolescent-hiv-communication-intervention-for-latinos-131626https://curecurrent.com/trials/treatment-with-indinavir-and-chemotherapy-for-advanced-classical-kaposi-s-sarcoma-131627https://curecurrent.com/trials/phase-iii-trial-of-bi-201335-faldaprevir-in-treatment-naive-tn-and-relapser-hepatitis-c-virus-hcv-human-immunodeficiency-131628https://curecurrent.com/trials/development-of-a-novel-hiv-risk-reduction-intervention-for-abused-women-131629https://curecurrent.com/trials/expanded-use-pk-of-dapivirine-vaginal-ring-131630https://curecurrent.com/trials/pennvax-b-with-or-without-il-12-or-il-15-as-a-dna-vaccine-for-hiv-infection-131631https://curecurrent.com/trials/esp-study-a-study-to-assess-the-effect-of-adding-fuzeon-enfuvirtide-to-an-antiretroviral-regimen-in-fuzeon-naive-patient-131632https://curecurrent.com/trials/maternal-hiv-disclosure-to-school-children-rct-of-family-based-intervention-131633https://curecurrent.com/trials/anal-dysplasia-study-of-men-who-have-sex-with-men-living-with-hiv-131634https://curecurrent.com/trials/high-dose-therapy-and-peripheral-blood-stem-cell-transplantation-in-hiv-related-non-hodgkin-lymphoma-nhl-at-high-risk-131635https://curecurrent.com/trials/hiv-risk-reduction-in-subutex-injectors-in-tbilisi-131636https://curecurrent.com/trials/safety-study-of-multikine-in-the-treatment-of-perianal-warts-131637https://curecurrent.com/trials/testing-and-linkage-to-hiv-care-in-china-131638https://curecurrent.com/trials/telaprevir-open-label-study-in-co-infected-patients-131639https://curecurrent.com/trials/low-dose-atazanavir-r-versus-standard-dose-atazanavir-r-lasa-131640https://curecurrent.com/trials/relationship-of-metabolic-abnormalities-to-hepatic-steatosis-in-hiv-131641https://curecurrent.com/trials/meaning-of-life-in-hiv-infected-youths-131642https://curecurrent.com/trials/factors-affecting-patient-participation-in-aids-malignancy-clinical-trials-consortium-clinical-trials-131643https://curecurrent.com/trials/impact-of-extremely-early-antiretroviral-therapy-to-reduce-viral-reservoir-and-induce-functional-cure-of-hiv-1-infection-131644https://curecurrent.com/trials/efficacy-of-drug-and-risk-counseling-among-methadone-patients-in-jakarta-indonesia-131645https://curecurrent.com/trials/efficacy-and-safety-of-peg-interferon-alpha-2a-plus-ribavirin-in-genotype-1-chronic-hepatitis-c-participants-co-infected-131646https://curecurrent.com/trials/blq-study-a-study-of-a-protease-inhibitor-with-fuzeon-enfuvirtide-in-treatment-experienced-patients-with-hiv-1-131647https://curecurrent.com/trials/ssat061-pk-of-dtg-and-evt-cobi-in-healthy-volunteers-131648https://curecurrent.com/trials/hiv-and-drug-use-in-georgian-women-131649https://curecurrent.com/trials/transitions-linkages-from-jail-to-community-131650https://curecurrent.com/trials/massage-therapy-for-hiv-positive-people-effects-on-anxiety-depression-hyperventilation-and-quality-of-life-131651https://curecurrent.com/trials/relative-bioavailability-study-of-gsk1265744-formulations-131652https://curecurrent.com/trials/cybersenga-internet-based-hiv-prevention-in-uganda-131653https://curecurrent.com/trials/tailored-nutrition-and-food-security-interventions-in-comprehensive-hiv-care-131654https://curecurrent.com/trials/hiv-prevention-and-trauma-treatment-in-men-who-have-sex-with-men-and-who-have-a-history-of-sexual-abuse-131655https://curecurrent.com/trials/birmingham-access-to-care-study-131656https://curecurrent.com/trials/efficacy-of-neuro-haart-in-patients-with-hiv-131657https://curecurrent.com/trials/hiv-prevention-in-very-high-risk-men-who-have-sex-with-men-131658https://curecurrent.com/trials/physiologic-investigation-of-the-renin-angiotensin-aldosterone-axis-in-hiv-131659https://curecurrent.com/trials/sofosbuvir-ribavirin-for-the-treatment-of-chronic-hepatitis-c-virus-genotype-1-in-hiv-coinfected-patients-receiving-fixe-131660https://curecurrent.com/trials/simplifying-the-shang-ring-technique-for-circumcision-of-men-and-boys-131661https://curecurrent.com/trials/comprehensive-analysis-of-hiv-reservoirs-in-chronically-infected-hiv-1-treated-patients-131662https://curecurrent.com/trials/medication-adherence-in-human-immunodeficiency-virus-hiv-131663https://curecurrent.com/trials/phase-i-trial-of-dar-901-131664https://curecurrent.com/trials/neurobehavioral-model-of-hiv-in-injection-drug-users-131665https://curecurrent.com/trials/a-phase-i-trial-to-assess-the-safety-of-tenofovir-gel-and-film-formulations-fame-04-131666https://curecurrent.com/trials/seroprevalence-of-chikungunya-at-the-end-of-the-first-chikungunya-outbreak-in-the-french-antilles-within-a-sample-of-pat-131667https://curecurrent.com/trials/the-effect-of-hpv-vaccination-on-recurrence-rates-in-hiv-patients-with-condylomata-131668https://curecurrent.com/trials/antiretroviral-treatment-simplified-follow-up-management-assessment-anrs-12110-stratall-131669https://curecurrent.com/trials/national-evaluation-of-pi-based-2nd-line-efficacy-in-cambodia-131670https://curecurrent.com/trials/computer-mi-for-tobacco-quitline-engagement-in-smokers-living-with-hiv-131671https://curecurrent.com/trials/thol-impilo-bringing-people-into-care-131672https://curecurrent.com/trials/efficacy-and-safety-of-ledipasvir-sofosbuvir-fixed-dose-combination-for-8-weeks-in-subjects-with-chronic-genotype-1-hcv-131673https://curecurrent.com/trials/study-of-anti-hiv-cellular-therapy-based-on-dendritic-cells-pulsed-with-chemically-inactivated-virus-131674https://curecurrent.com/trials/heart-function-in-hiv-negative-children-exposed-to-hiv-and-haart-131675https://curecurrent.com/trials/early-versus-delayed-antiretroviral-therapy-art-in-the-treatment-of-cryptococcal-meningitis-in-africa-131676https://curecurrent.com/trials/the-effect-of-an-enhanced-rice-bran-nutritional-supplement-in-hiv-131677https://curecurrent.com/trials/pro-140-by-iv-administration-in-adults-with-hiv-1-infection-131678https://curecurrent.com/trials/study-of-vitamin-d-and-effect-on-heart-disease-and-insulin-resistance-131679https://curecurrent.com/trials/a-cross-sectional-evaluation-of-the-development-in-children-age-4-to-7-infected-or-exposed-to-hiv-from-the-anrs-12140-co-131680https://curecurrent.com/trials/h1n1-influenza-vaccine-immunogenicity-in-hiv-1-infected-patients-131681https://curecurrent.com/trials/values-of-the-immune-activation-markers-cd38-and-hla-dr-and-the-ratio-cd4-cd8-according-to-the-delay-of-combined-antiret-131682https://curecurrent.com/trials/physiopathology-study-of-the-microbiota-biodiversity-of-hiv-seropositive-patients-131683https://curecurrent.com/trials/evaluation-of-simplified-antiretroviral-treatment-strategies-in-hiv-infected-children-treated-by-antiretroviral-arv-befo-131684https://curecurrent.com/trials/viral-activation-transfusion-study-vats-131685https://curecurrent.com/trials/disability-and-hiv-vulnerability-of-people-with-disabilities-to-hiv-infection-in-sub-saharan-africa-131686https://curecurrent.com/trials/study-evaluating-efficiency-and-tolerance-of-high-dose-fluconazole-associated-with-flucytosine-as-induction-therapy-for-131687https://curecurrent.com/trials/assessing-the-severity-of-metabolic-related-liver-injuries-in-aging-hiv-monoinfected-patients-131688https://curecurrent.com/trials/immuno-stimulation-with-maraviroc-combined-to-antiretroviral-therapy-in-advanced-late-diagnosed-hiv-1-infected-patients-131689https://curecurrent.com/trials/vitamin-d-and-calcium-supplement-attenuate-bone-loss-among-hiv-infected-patients-receiving-tenofovir-disoproxil-fumarate-131690https://curecurrent.com/trials/epicardial-adipose-tissue-and-coronary-risk-in-hiv-infected-patients-131691https://curecurrent.com/trials/a-study-of-enfuvirtide-fuzeon-in-participants-with-advanced-human-immunodeficiency-virus-hiv-infection-131692https://curecurrent.com/trials/pet-ct-in-extrapulmonary-tb-in-hiv-patients-a-clinical-trial-131693https://curecurrent.com/trials/expanded-access-program-for-maraviroc-at-multiple-centers-131694https://curecurrent.com/trials/observational-retrospective-multicenter-study-to-describe-the-reasons-for-the-change-of-the-regimen-of-antiretroviral-th-131695https://curecurrent.com/trials/a-prospective-with-one-site-open-label-not-controled-trial-for-the-observation-of-treatment-with-cidofovir-1-3-nights-pe-131696https://curecurrent.com/trials/vitamin-d-and-hiv-cardiovascular-disease-in-children-and-young-adults-131697https://curecurrent.com/trials/relative-oral-bioavailability-study-of-different-fixed-dose-combinations-of-dolutegravir-and-rilpivirine-in-healthy-subj-131698https://curecurrent.com/trials/a-study-of-the-neurological-effects-of-adding-raltegravir-to-haart-regimen-in-patients-with-hiv-131699https://curecurrent.com/trials/test-of-an-intervention-to-improve-hiv-care-131700https://curecurrent.com/trials/incentives-to-promote-medication-adherence-among-hiv-infected-youth-131701https://curecurrent.com/trials/metabolic-abnormalities-in-hiv-infected-persons-131702https://curecurrent.com/trials/an-efficacy-and-safety-study-of-autologous-cluster-of-differentiation-34-cd34-hematopoietic-progenitor-cells-transduced-131703https://curecurrent.com/trials/assessment-of-vac-3s-therapeutic-properties-when-combined-with-standard-art-in-the-course-of-hiv-1-infection-131704https://curecurrent.com/trials/open-label-phase-i-iia-study-of-vac-3s-in-hiv-1-patients-who-showed-an-immune-response-to-vac-3s-during-ivvac-3s-p1-131705https://curecurrent.com/trials/factors-associated-with-late-hiv-diagnosis-in-grampian-an-epidemiological-study-131706https://curecurrent.com/trials/ace-inhibitors-to-decrease-lymphoid-fibrosis-in-antiretroviral-treated-hiv-infected-patients-a-pilot-study-131707https://curecurrent.com/trials/validation-of-a-simple-and-cost-effective-nucleic-acid-test-for-hiv-detection-131708https://curecurrent.com/trials/health-related-symptom-questionnaires-in-measuring-quality-of-life-in-hiv-infected-participants-treated-or-monitored-for-131709https://curecurrent.com/trials/study-to-evaluate-switching-from-regimens-consisting-of-a-ritonavir-boosted-protease-inhibitor-plus-emtricitabine-tenofo-131710https://curecurrent.com/trials/safety-and-immunogenicity-of-mva-hivconsv-in-hiv-1-seropositive-adults-on-haart-131711https://curecurrent.com/trials/evaluation-of-the-safety-efficacy-and-pharmacokinetics-of-intravenous-deferiprone-in-hiv-positive-subjects-131712https://curecurrent.com/trials/the-use-of-hiv-self-tests-to-promote-partner-and-couples-testing-a-randomized-trial-131713https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-2-dose-levels-of-trimeric-glycoprotein140-gp140-in-healthy-adult-volunte-131714https://curecurrent.com/trials/evaluating-once-daily-etravirine-in-treatment-naive-adults-with-hiv-infection-131715https://curecurrent.com/trials/the-use-of-peer-referral-incentives-to-increase-demand-for-voluntary-medical-male-circumcision-in-zambia-131716https://curecurrent.com/trials/effects-of-treatment-with-aprepitant-emend-in-hiv-infected-individuals-375-mg-dose-131717https://curecurrent.com/trials/bone-mineral-density-in-hiv-patients-131718https://curecurrent.com/trials/fatigue-management-in-hiv-131719https://curecurrent.com/trials/fracture-and-bone-mineral-density-in-hiv-patients-recently-started-on-antiretroviral-therapy-art-131720https://curecurrent.com/trials/targeted-nurse-driven-hiv-screening-in-emergency-departments-131721https://curecurrent.com/trials/pilot-study-of-raltegravir-truvada-versus-efavirenz-truvada-for-adults-with-acute-iv-1-infection-131722https://curecurrent.com/trials/safety-immunogenicity-of-hiv-vaccines-in-healthy-kenyan-adults-131723https://curecurrent.com/trials/multicenter-randomized-double-blind-double-dummy-phase-3-study-of-the-safety-and-efficacy-of-elvitegravir-versus-raltegr-131724https://curecurrent.com/trials/safety-pk-and-pd-study-of-abx464-in-untreated-hiv-patients-131725https://curecurrent.com/trials/the-tolerability-of-and-adherence-to-dolutegravir-with-co-formulated-tenofovir-emtricitabine-for-hiv-non-occupational-po-131726https://curecurrent.com/trials/haart-adherence-among-hiv-infected-persons-and-the-factors-affecting-treatment-adherence-131727https://curecurrent.com/trials/a-study-of-mva85a-in-healthy-infants-131728https://curecurrent.com/trials/primary-hiv-prevention-in-pregnant-and-lactating-ugandan-women-131729https://curecurrent.com/trials/efficacy-against-tb-disease-safety-and-immunogenicity-of-mva85a-aeras-485-in-hiv-infected-adults-c-030-485-131730https://curecurrent.com/trials/safety-and-efficacy-of-cobi-boosted-atazanavir-versus-ritonavir-boosted-atazanavir-each-administered-with-emtricitabine-131731https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-raltegravir-isentress-administered-in-combination-with-other-antiretroviral-drugs-as-t-131732https://curecurrent.com/trials/nutritional-and-metabolic-disorders-in-hiv-infected-children-and-adolescent-131733https://curecurrent.com/trials/hiv-prevention-for-youth-with-severe-mental-illness-131734https://curecurrent.com/trials/effectiveness-of-enhanced-counseling-and-observed-therapy-on-antiretroviral-adherence-in-people-with-hiv-131735https://curecurrent.com/trials/formative-phase-of-reducing-hazardous-alcohol-use-hiv-viral-load-131736https://curecurrent.com/trials/syphilis-response-to-higher-penicillin-dosage-the-2-4-versus-7-2-study-131737https://curecurrent.com/trials/measurement-of-hiv-risk-to-create-demand-for-safe-male-circumcision-131738https://curecurrent.com/trials/a-mindfulness-based-approach-to-hiv-treatment-side-effects-131739https://curecurrent.com/trials/determination-of-hcv-prevalence-in-a-hiv-patient-cohort-in-phnom-penh-cambodia-131740https://curecurrent.com/trials/benefits-and-costs-of-integrating-sexual-reproductive-health-and-hiv-services-in-kenya-and-swaziland-131741https://curecurrent.com/trials/pre-art-retention-in-care-in-tanzania-131742https://curecurrent.com/trials/brain-deficits-in-hiv-hcv-coinfected-people-before-and-after-anti-hcv-therapy-131743https://curecurrent.com/trials/rct-of-russian-idu-peer-network-hiv-prevention-intervention-1-131744https://curecurrent.com/trials/feasibility-of-an-exercise-intervention-131745https://curecurrent.com/trials/dna-sequencing-of-mdr-tb-in-eastern-siberia-131746https://curecurrent.com/trials/can-valacyclovir-attenuate-inflammation-in-antiretroviral-treated-hiv-infected-individuals-with-herpes-simplex-virus-typ-131747https://curecurrent.com/trials/second-line-therapy-131748https://curecurrent.com/trials/progress-adult-study-131749https://curecurrent.com/trials/sexually-transmitted-infections-among-african-american-women-who-have-sex-with-women-131750https://curecurrent.com/trials/sti-hiv-prevention-intervention-for-adolescents-in-singapore-131751https://curecurrent.com/trials/pharmacotherapy-follow-up-in-older-hiv-infected-patients-131752https://curecurrent.com/trials/improving-survey-procedures-for-young-men-who-have-sex-with-men-in-web-based-hiv-prevention-retention-study-131753https://curecurrent.com/trials/vaginal-innate-immunity-in-normal-and-hiv-infected-women-131754https://curecurrent.com/trials/rct-of-cbt-for-insomnia-with-plwha-131755https://curecurrent.com/trials/an-efficacy-and-safety-study-of-telaprevir-in-patients-infected-with-both-chronic-hepatitis-c-virus-hcv-1-and-human-immu-131756https://curecurrent.com/trials/targeting-hiv-risk-behaviors-in-juvenile-drug-court-involved-youth-131757https://curecurrent.com/trials/maraviroc-compassionate-use-131758https://curecurrent.com/trials/clinical-trial-of-recombinant-adenovirus-type-5-aids-vaccine-131759https://curecurrent.com/trials/cobicistat-containing-highly-active-antiretroviral-regimens-in-hiv-1-infected-patients-with-mild-to-moderate-renal-impai-131760https://curecurrent.com/trials/introducing-prep-into-hiv-combination-prevention-kenya-131761https://curecurrent.com/trials/a-phase-i-study-to-evaluate-safety-and-immunogenicity-of-aeras-404-c-011-404-131762https://curecurrent.com/trials/a-study-to-evaluate-safety-and-immunogenicity-of-aeras-402-administered-in-hiv-negative-bcg-vaccinated-qft-and-adults-wi-131763https://curecurrent.com/trials/assessment-of-the-hiv-cns-reservoir-neurological-and-neuro-cognitive-effects-and-source-of-rebound-hiv-in-cns-131764https://curecurrent.com/trials/interventions-to-improve-hiv-care-engagement-after-hospital-discharge-131765https://curecurrent.com/trials/international-social-network-intervention-131766https://curecurrent.com/trials/safety-of-evg-rtv-administered-with-other-antiretroviral-agents-for-the-treatment-of-hiv-1-infection-131767https://curecurrent.com/trials/early-access-of-mk0518-in-combination-with-an-optimized-background-antiretroviral-therapy-0518-023-131768https://curecurrent.com/trials/mhealth-intervention-supporting-hiv-treatment-adherence-and-retention-131769https://curecurrent.com/trials/comorbidities-and-virologic-outcome-among-patients-on-anti-retroviral-therapy-in-rural-lesotho-131770https://curecurrent.com/trials/reduction-of-early-mortality-in-hiv-infected-adults-and-children-starting-antiretroviral-therapy-131771https://curecurrent.com/trials/substance-use-and-sexual-risk-reduction-intervention-for-homeless-youth-131772https://curecurrent.com/trials/retrovirus-epidemiology-donor-study-i-reds-i-131773https://curecurrent.com/trials/retrovirus-epidemiology-donor-study-ii-reds-ii-131774https://curecurrent.com/trials/transfusion-safety-study-tss-131775https://curecurrent.com/trials/anti-hiv-immunoglobulin-hivig-in-prevention-of-maternal-fetal-hiv-transmission-pediatric-actg-protocol-185-131776https://curecurrent.com/trials/extended-release-naltrexone-to-treat-methamphetamine-dependence-in-men-who-have-sex-with-men-msm-131777https://curecurrent.com/trials/d-c-f-taf-versus-cobi-boosted-drv-plus-ftc-tdf-in-hiv-1-infected-antiretroviral-treatment-naive-adults-131778https://curecurrent.com/trials/efficacy-and-safety-study-of-optimized-background-antiretroviral-regimen-ob-in-combination-with-enfuvirtide-in-the-treat-131779https://curecurrent.com/trials/a-study-to-evaluate-safety-acceptability-pharmacokinetics-and-ex-vivo-pharmacodynamics-of-tmc278-long-acting-formulation-131780https://curecurrent.com/trials/transmission-reduction-intervention-project-131781https://curecurrent.com/trials/a-non-inferiority-randomized-controlled-trial-to-evaluate-promoting-condom-use-among-msm-and-transgender-individuals-in-131782https://curecurrent.com/trials/impaact-p1063-safety-and-effectiveness-of-atorvastatin-in-hiv-infected-children-and-adolescents-with-hyperlipidemia-131783https://curecurrent.com/trials/eliciting-affect-in-teens-in-a-virtual-world-project-avatar-131784https://curecurrent.com/trials/improving-nicotine-patch-adherence-among-latino-hiv-positive-smokers-131785https://curecurrent.com/trials/effects-of-intensive-cart-during-acute-early-hiv-infection-131786https://curecurrent.com/trials/clinical-trial-of-brain-penetrating-hiv-drugs-to-prevent-cognitive-impairment-in-china-131787https://curecurrent.com/trials/a-post-marketing-survey-study-to-evaluate-the-safety-and-effectiveness-of-intelence-131788https://curecurrent.com/trials/hiv-aids-severe-mental-illness-and-homelessness-131789https://curecurrent.com/trials/effects-of-maternal-anti-hiv-treatment-on-infants-born-to-hiv-infected-women-131790https://curecurrent.com/trials/tmc278-tidp6-c215-a-clinical-trial-in-treatment-naive-hiv-subjects-patients-comparing-tmc278-to-efavirenz-in-combination-131791https://curecurrent.com/trials/mmr-vaccination-among-hiv-infected-adults-131792https://curecurrent.com/trials/dutch-acute-hcv-in-hiv-study-dahhs-131793https://curecurrent.com/trials/routine-use-of-antiretroviral-therapy-to-prevent-mother-to-child-hiv-transmission-in-the-kafue-district-of-zambia-131794https://curecurrent.com/trials/prevention-of-transmission-of-sexually-transmitted-diseases-in-the-youth-through-effective-intervention-131795https://curecurrent.com/trials/a-mixed-methods-approach-to-understanding-factors-associated-with-cervical-cancer-screening-utilization-among-low-income-131796https://curecurrent.com/trials/tmc278-tidp6-c209-a-clinical-trial-in-treatment-naive-hiv-1-patients-comparing-tmc278-to-efavirenz-in-combination-with-t-131797https://curecurrent.com/trials/urban-health-study-ii-131798https://curecurrent.com/trials/use-of-a-nutritional-supplement-to-treat-diabetic-symptoms-in-hiv-infected-adults-131799https://curecurrent.com/trials/the-effectiveness-of-a-counselling-intervention-on-the-uptake-of-hiv-care-services-among-hiv-infected-patients-in-uganda-131800https://curecurrent.com/trials/penetration-and-compartimentation-of-hiv-131801https://curecurrent.com/trials/effects-of-igf-i-in-hiv-metabolic-disease-131802https://curecurrent.com/trials/ssat067-pk-of-atazanavir-cobicistat-and-darunavir-cobicistat-131803https://curecurrent.com/trials/exploring-novel-mechanisms-of-vaccine-failure-laiv-pilot-study-131804https://curecurrent.com/trials/diet-exercise-niacin-and-fenofibrate-to-reduce-heart-disease-risk-factors-in-individuals-with-hiv-lipodystrophy-or-dysli-131805https://curecurrent.com/trials/rh-and-adolescents-131806https://curecurrent.com/trials/manhattan-hiv-hepatology-brain-bank-131807https://curecurrent.com/trials/como-cognition-study-with-hiv-patients-ctnpt-015-131808https://curecurrent.com/trials/aids-associated-heart-disease-incidence-and-etiology-131809https://curecurrent.com/trials/hiv-diversity-and-pathogenesis-in-donor-recipient-clusters-131810https://curecurrent.com/trials/pulmonary-complications-of-hiv-infection-study-pacs-131811https://curecurrent.com/trials/topiramate-to-reduce-heavy-drinking-in-hiv-positive-heavy-drinkers-131812https://curecurrent.com/trials/hospital-visit-as-opportunity-for-prevention-and-engagement-for-hiv-infected-drug-users-131813https://curecurrent.com/trials/studies-of-ocular-complications-of-aids-soca-ganciclovir-cidofovir-cmv-retinitis-trial-gccrt-131814https://curecurrent.com/trials/sleep-and-cognition-after-atripla-to-stribild-switch-131815https://curecurrent.com/trials/kshv-infection-in-blood-donors-from-texas-131816https://curecurrent.com/trials/measurement-of-glomerular-filtration-rate-gfr-in-hiv-patients-single-center-study-comparing-the-accuracy-of-estimators-o-131817https://curecurrent.com/trials/adherence-support-intervention-for-persons-living-with-hiv-aids-plwha-on-antiretroviral-therapy-art-in-estonia-131818https://curecurrent.com/trials/use-of-rosuvastatin-in-hiv-infected-subjects-to-modulate-cardiovascular-risks-131819https://curecurrent.com/trials/a-pilot-study-of-a-dendritic-cell-vaccine-in-hiv-1-infected-subjects-131820https://curecurrent.com/trials/screening-for-tuberculosis-in-hiv-infected-patients-eligible-for-antiretroviral-treatment-131821https://curecurrent.com/trials/smf-to-improve-performance-of-microscopy-for-the-diagnosis-of-ptb-in-a-high-hiv-prevalence-setting-131822https://curecurrent.com/trials/utilization-of-hiv-clinical-services-in-rural-india-131823https://curecurrent.com/trials/screening-for-hiv-associated-anal-cancer-131824https://curecurrent.com/trials/a-study-of-invirase-saquinavir-ritonavir-in-hiv-infected-infants-and-children-131825https://curecurrent.com/trials/observational-study-on-anti-tat-immune-response-in-hiv-1-infected-haart-treated-adult-subjects-131826https://curecurrent.com/trials/observational-study-on-anti-tat-immune-response-in-hiv-1-infected-asymptomatic-adult-subjects-131827https://curecurrent.com/trials/study-to-assess-the-seroprevalence-of-anti-tat-antibodies-in-hiv-infected-patients-131828https://curecurrent.com/trials/early-hiv-therapy-in-patients-with-high-cd4-cell-counts-131829https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-preventive-vaccine-trial-based-on-the-hiv-1-tat-and-v2-deleted-env-proteins-iss-p-00-131830https://curecurrent.com/trials/a-phase-il-of-a-therapeutic-recombinant-biologically-active-hiv-1-tat-protein-vaccine-in-hiv-infected-anti-tat-negative-131831https://curecurrent.com/trials/immunogenicity-and-safety-trial-of-the-hiv-1-tat-vaccine-131832https://curecurrent.com/trials/affect-management-for-early-adolescents-131833https://curecurrent.com/trials/a-study-to-assess-cerebrospinal-fluid-inflammatory-markers-after-addition-of-maraviroc-to-monotherapy-darunavir-ritonavi-131834https://curecurrent.com/trials/smoking-cessation-for-hiv-aids-patients-131835https://curecurrent.com/trials/operational-assessment-of-point-of-care-diagnostics-in-primary-healthcare-clinics-131836https://curecurrent.com/trials/home-based-partner-education-and-testing-hope-study-131837https://curecurrent.com/trials/centralized-off-site-adherence-enhancement-program-131838https://curecurrent.com/trials/hcv-hiv-coinfection-antiviral-therapy-and-fibrosis-131839https://curecurrent.com/trials/backup-with-combivir-or-single-dose-sd-truvada-in-order-to-avoid-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-re-131840https://curecurrent.com/trials/comparison-of-cervical-cancer-screening-tests-in-hiv-infected-women-in-lusaka-zambia-131841https://curecurrent.com/trials/remune-amplivax-ir103-hiv-aids-phase-iii-safety-efficacy-study-131842https://curecurrent.com/trials/remune-hiv-aids-vaccine-phase-ii-pediatric-safety-efficacy-clinical-study-131843https://curecurrent.com/trials/estimating-the-global-need-for-palliative-care-for-children-131844https://curecurrent.com/trials/abacavir-and-lamivudine-pk-in-children-131845https://curecurrent.com/trials/intrauterine-insemination-in-hiv-discordant-couples-131846https://curecurrent.com/trials/progress-pediatric-study-131847https://curecurrent.com/trials/maternal-fetal-cd4-microchimerism-in-hiv-exposed-newborns-after-spontaneous-delivery-and-cesarean-section-131848https://curecurrent.com/trials/efficacy-of-tenofovir-and-emtricitabine-in-arv-naive-patients-with-hiv-hbv-co-infection-131849https://curecurrent.com/trials/efficacy-of-intrathecal-administration-of-liposomal-amphotericin-b-in-cryptococcal-meningitis-131850https://curecurrent.com/trials/investigational-vaccine-for-the-prevention-of-disseminated-tuberculosis-in-hiv-infected-people-131851https://curecurrent.com/trials/cardiac-autonomic-control-in-children-of-hiv-positive-mothers-131852https://curecurrent.com/trials/development-of-a-family-intervention-to-address-drug-use-and-hiv-in-vietnam-131853https://curecurrent.com/trials/aids-associated-cardiomyopathy-131854https://curecurrent.com/trials/hiv-associated-heart-disease-131855https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-immunogenicity-of-heterologous-boost-immunizations-with-mva-cmdr-131856https://curecurrent.com/trials/safety-and-efficacy-of-cobicistat-boosted-atazanavir-compared-to-ritonavir-boosted-atazanavir-in-combination-with-emtric-131857https://curecurrent.com/trials/t-20-plus-a-selected-anti-hiv-treatment-in-hiv-infected-children-and-adolescents-131858https://curecurrent.com/trials/eban-ii-intervention-for-hiv-sero-discordant-couples-131859https://curecurrent.com/trials/effect-of-bacterial-vaginosis-on-hiv-susceptibility-and-female-genital-immunology-131860https://curecurrent.com/trials/the-effect-of-hiv-tat-protein-on-hcv-replication-in-an-in-vitro-model-system-131861https://curecurrent.com/trials/evaluation-on-seropositive-patients-of-a-synthetic-vaccine-targeting-the-hiv-tat-protein-131862https://curecurrent.com/trials/pre-exposure-prophylaxis-adherence-intervention-for-msm-131863https://curecurrent.com/trials/immune-and-viral-outcomes-of-hiv-1-therapy-interruption-131864https://curecurrent.com/trials/effectiveness-of-mobile-phone-technology-on-adherence-and-treatment-outcomes-among-hiv-positive-patients-on-art-131865https://curecurrent.com/trials/truvada-plus-raltegravir-for-nonoccupational-post-exposure-prophylaxis-npep-131866https://curecurrent.com/trials/n-acetylcysteine-to-reduce-oxidative-stress-and-improve-endothelial-function-in-hiv-infected-older-adults-131867https://curecurrent.com/trials/switch-to-darunavir-r-maraviroc-quaque-die-in-patients-with-r5-tropism-by-viral-dna-genotyping-gusta-131868https://curecurrent.com/trials/immune-reconstitution-in-hiv-disease-irehiv-131869https://curecurrent.com/trials/minocycline-for-the-treatment-of-decreased-mental-function-in-hiv-infected-adults-131870https://curecurrent.com/trials/pilot-study-of-a-raltegravir-based-nrti-sparing-regimen-131871https://curecurrent.com/trials/pharmacokinetic-pk-study-of-single-dose-rosuvastatin-and-tipranavir-ritonavir-in-healthy-subjects-131872https://curecurrent.com/trials/endothelial-function-lipoproteins-and-inflammation-with-low-hdl-cholesterol-in-hiv-er-niacin-versus-fenofibrate-131873https://curecurrent.com/trials/zidovudine-plus-interleukin-2-and-ganciclovir-in-treating-patients-with-aids-related-primary-central-nervous-system-lymp-131874https://curecurrent.com/trials/peripheral-stem-cell-transplantation-followed-by-infusion-of-white-blood-cells-in-treating-patients-with-aids-related-ly-131875https://curecurrent.com/trials/chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-recurrent-or-refractory-aids-rel-131876https://curecurrent.com/trials/hiv-prevention-among-latino-msm-evaluation-of-a-locally-developed-intervention-131877https://curecurrent.com/trials/dose-optimisation-of-stavudine-for-the-treatment-of-hiv-infection-131878https://curecurrent.com/trials/an-enhanced-adherence-support-programme-for-highly-active-antiretroviral-therapy-haart-131879https://curecurrent.com/trials/effect-of-haart-vs-statin-treatment-on-endothelial-function-and-inflammation-coagulation-131880https://curecurrent.com/trials/safety-and-effectiveness-study-of-a-candidate-vaginal-microbicide-for-prevention-of-hiv-131881https://curecurrent.com/trials/peripheral-arterial-insufficiency-associated-with-hiv-aids-131882https://curecurrent.com/trials/safety-and-efficacy-study-of-daclatasvir-bms-790052-plus-pegylated-interferon-alfa-2a-and-ribavirin-in-patients-coinfect-131883https://curecurrent.com/trials/addressing-discrimination-and-mistrust-among-black-men-phase-iii-131884https://curecurrent.com/trials/maternal-infant-peripartum-nvp-versus-infant-only-peripartum-nvp-or-maternal-lpv-r-in-addition-to-standard-zdv-prophylax-131885https://curecurrent.com/trials/comparison-of-tenofovir-vaginal-gel-and-film-formulations-131886https://curecurrent.com/trials/leptin-for-abnormal-lipid-kinetics-in-hiv-lipodystrophy-syndrome-131887https://curecurrent.com/trials/peer-education-program-for-hiv-aids-related-sexual-behaviors-of-secondary-school-students-131888https://curecurrent.com/trials/4-consecutive-days-on-treatment-followed-by-3-days-off-treatment-in-hiv-patients-131889https://curecurrent.com/trials/safety-and-immunogenicity-study-of-a-dna-vaccine-combined-with-protein-vaccine-against-hiv-aids-131890https://curecurrent.com/trials/oral-human-papillomavirus-infection-in-hiv-infected-men-131891https://curecurrent.com/trials/viral-load-determination-and-biomarkers-of-high-risk-human-papillomavirus-hpv-types-in-hiv-positive-men-131892https://curecurrent.com/trials/march-central-nervous-system-substudy-131893https://curecurrent.com/trials/a-phase-2b-evaluation-of-daclatasvir-sofosbuvir-in-non-cirrhotic-treatment-naive-subjects-with-genotype-1-2-3-and-4-chro-131894https://curecurrent.com/trials/march-renal-substudy-131895https://curecurrent.com/trials/maraviroc-switch-collaborative-study-131896https://curecurrent.com/trials/daily-co-trimoxazole-prophylaxis-to-prevent-malaria-in-pregnancy-131897https://curecurrent.com/trials/cardiovascular-risk-in-hiv-patients-on-antiretroviral-therapy-therapy-the-mheart-study-131898https://curecurrent.com/trials/improving-consent-and-survey-procedures-for-young-msm-in-web-based-hiv-prevention-131899https://curecurrent.com/trials/study-of-pro-140-by-subcutaneous-administration-in-adult-subjects-with-hiv-1-infection-131900https://curecurrent.com/trials/comparative-trial-of-maraviroc-versus-emtricitabine-tenofovir-both-with-darunavir-ritonavir-in-antiretroviral-naive-pati-131901https://curecurrent.com/trials/expansion-to-interdisciplinary-hiv-prevention-in-women-131902https://curecurrent.com/trials/lactate-metabolism-study-in-hiv-infected-persons-131903https://curecurrent.com/trials/the-effects-of-anabolic-steroids-and-protease-inhibitors-on-people-living-with-hiv-aids-131904https://curecurrent.com/trials/gut-associated-lymphatic-tissue-galt-in-hiv-human-immunodeficiency-virus-infected-patients-131905https://curecurrent.com/trials/impact-of-antiretroviral-therapy-on-metabolic-skeletal-and-cardiovascular-parameters-131906https://curecurrent.com/trials/phase-i-one-month-safety-pk-pd-and-acceptability-study-of-ivr-releasing-tfv-and-lng-or-tfv-alone-131907https://curecurrent.com/trials/study-to-evaluate-switching-from-regimens-consisting-of-a-nonnucleoside-reverse-transcriptase-inhibitor-plus-emtricitabi-131908https://curecurrent.com/trials/a-phase-i-multiple-dose-pharmacokinetic-study-of-nevirapine-extended-release-xr-in-hiv-1-infected-children-131909https://curecurrent.com/trials/a-study-to-assess-dolutegravir-in-hiv-infected-subjects-with-treatment-failure-on-an-integrase-inhibitor-containing-regi-131910https://curecurrent.com/trials/effect-of-rifampin-rif-on-the-pharmacokinetics-pk-of-oral-cabotegravir-cab-in-healthy-subjects-131911https://curecurrent.com/trials/effect-of-community-social-mobilization-for-the-prevention-of-hiv-in-young-south-african-women-131912https://curecurrent.com/trials/depression-amongst-hiv-positive-patients-in-lilongwe-131913https://curecurrent.com/trials/addition-of-ezetimibe-ezetrol-to-ongoing-therapy-with-rosuvastatin-crestor-in-hiv-positive-patients-not-reaching-cholest-131914https://curecurrent.com/trials/changes-in-triglyceride-and-other-lipids-levels-of-fats-found-in-blood-when-taking-darunavir-compared-to-atazanavir-in-h-131915https://curecurrent.com/trials/renal-and-bone-outcome-after-switching-tenofovir-to-different-antiretroviral-strategies-131916https://curecurrent.com/trials/pilot-study-of-maraviroc-raltegravir-for-naive-hiv-1-patients-131917https://curecurrent.com/trials/safety-and-antiviral-study-of-ach-126-443-beta-l-fd4c-in-the-treatment-of-adults-with-hiv-infection-and-modestly-detecta-131918https://curecurrent.com/trials/tuberculosis-in-a-multiethnic-inner-city-population-131919https://curecurrent.com/trials/antiretroviral-therapy-and-inflammatory-and-coagulation-biomarkers-imacs-study-131920https://curecurrent.com/trials/mother-infant-retention-for-health-mir4health-131921https://curecurrent.com/trials/pharmacokinetic-interactions-between-dmpa-and-lpv-r-among-hiv-infected-women-131922https://curecurrent.com/trials/cidofovir-in-treating-hiv-infected-patients-with-high-grade-squamous-intraepithelial-lesions-of-the-skin-near-the-anus-131923https://curecurrent.com/trials/vicriviroc-in-hiv-r5-x4-treatment-experienced-subjects-study-p05057am5-completed-131924https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-study-of-abacavir-dolutegravir-lamivudine-fixed-dose-combination-tablets-in-hea-131925https://curecurrent.com/trials/weltel-retain-promoting-engagement-in-pre-art-hiv-care-through-sms-131926https://curecurrent.com/trials/bryostatin-1-effect-on-hiv-1-latency-and-reservoir-in-hiv-1-infected-patients-receiving-antiretroviral-treatment-131927https://curecurrent.com/trials/transfusion-infections-pediatric-prospective-study-tripps-131928https://curecurrent.com/trials/influenza-vaccine-in-hiv-study-131929https://curecurrent.com/trials/feasibility-of-measuring-immune-resp-activation-in-foreskin-mucosa-in-hiv-uncircumcised-high-hiv-risk-msm-lima-peru-131930https://curecurrent.com/trials/veterans-living-with-hiv-aids-a-pilot-study-examining-risk-factors-associated-with-self-directed-violence-131931https://curecurrent.com/trials/the-canadian-hiv-quit-smoking-trial-tackling-the-co-morbidities-of-depression-and-cardiovascular-disease-in-hiv-smokers-131932https://curecurrent.com/trials/t1-mapping-in-hiv-patients-with-high-and-low-cd4-cell-counts-131933https://curecurrent.com/trials/a-safety-study-of-dapivirine-tmc120-vaginal-microbicide-gel-in-south-africa-131934https://curecurrent.com/trials/pediatric-enhanced-surveillance-study-131935https://curecurrent.com/trials/evaluating-an-exercise-program-to-reduce-cardiovascular-risk-factors-in-children-infected-with-hiv-131936https://curecurrent.com/trials/study-to-evaluate-switching-from-regimens-consisting-of-a-ritonavir-boosted-protease-inhibitor-pi-and-two-nucleoside-rev-131937https://curecurrent.com/trials/safety-and-efficacy-of-an-investigational-drug-in-human-immunodeficiency-virus-hiv-infected-patients-failing-current-ant-131938https://curecurrent.com/trials/a-pilot-study-assessing-the-integrase-inhibitor-gsk1349572-in-hiv-infected-persons-with-virus-resistant-to-raltegravir-131939https://curecurrent.com/trials/differences-in-blood-levels-of-lopinavir-ritonavir-in-hiv-infected-men-and-women-131940https://curecurrent.com/trials/clinical-implications-of-hiv-low-level-viremia-at-times-of-highly-active-antiretroviral-treatment-regimens-131941https://curecurrent.com/trials/hiv-prevention-among-substance-abusing-smi-131942https://curecurrent.com/trials/a-comparison-of-immediate-treatment-of-cin1-with-cryotherapy-and-12-month-cytology-follow-up-in-hiv-seropositive-women-131943https://curecurrent.com/trials/assessing-short-and-long-term-compliance-with-caloric-intake-in-hiv-positive-women-taking-complera-131944https://curecurrent.com/trials/healthy-beginning-initiative-131945https://curecurrent.com/trials/hiv-discordant-couple-intrauterine-insemination-131946https://curecurrent.com/trials/a-study-to-assess-the-safety-and-effectiveness-of-darunavir-for-treating-human-immunodeficiency-virus-type-i-hiv-1-infec-131947https://curecurrent.com/trials/a-study-on-the-safety-and-effectiveness-of-rilpivirine-hydrochloride-edurant-among-adult-filipino-patients-with-human-im-131948https://curecurrent.com/trials/the-role-of-genital-warts-in-hiv-acquisition-in-peru-131949https://curecurrent.com/trials/pediatric-expanded-access-program-oral-solution-0831-908-131950https://curecurrent.com/trials/multicentre-study-to-assess-changes-in-bone-mineral-density-of-the-switch-from-protease-inhibitors-to-dolutegravir-in-hi-131951https://curecurrent.com/trials/valganciclovir-in-treating-patients-with-classic-non-hiv-associated-kaposi-s-sarcoma-131952https://curecurrent.com/trials/study-of-integrating-antiretroviral-therapy-with-methadone-treatment-for-people-who-inject-drugs-131953https://curecurrent.com/trials/optimizing-kidney-transplant-informed-consent-131954https://curecurrent.com/trials/immune-activation-in-hiv-1-infected-patients-under-antiretroviral-treatment-131955https://curecurrent.com/trials/immune-response-after-booster-vaccination-in-hiv-infected-patients-who-received-rabies-primary-vaccination-131956https://curecurrent.com/trials/deep-vein-thrombosis-treatment-with-the-oral-direct-factor-xa-inhibitor-rivaroxaban-in-patients-using-a-strong-cyp-3a4-i-131957https://curecurrent.com/trials/nevirapine-dosing-in-neonates-for-prophylaxis-of-mother-to-child-transmission-mtct-of-hiv-infection-131958https://curecurrent.com/trials/effect-of-a-micro-finance-based-intervention-for-the-prevention-of-intimate-partner-violence-and-hiv-131959https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-hpmpc-peripheral-cmv-retinitis-trial-hpcrt-131960https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-monoclonal-antibody-cmv-retinitis-trial-macrt-131961https://curecurrent.com/trials/anal-hpv-infection-and-abnormal-cytology-in-hiv-infected-women-131962https://curecurrent.com/trials/bioequivalence-study-between-lamivudine-formulations-in-the-form-of-coated-tablet-of-150-mg-in-healthy-volunteers-131963https://curecurrent.com/trials/evaluation-of-3tc-or-ftc-mono-therapy-compared-to-continuing-haart-as-a-bridging-strategy-131964https://curecurrent.com/trials/linking-hospitalized-injection-drug-users-to-buprenorphine-131965https://curecurrent.com/trials/hepatic-safety-of-currently-used-antiretroviral-regimens-in-patients-with-chronic-hepatitis-under-real-life-conditions-131966https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-stribild-versus-atripla-in-human-immunodeficiency-virus-type-1-hiv-1-infect-131967https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-stribild-versus-ritonavir-boosted-atazanavir-plus-truvada-in-human-immunode-131968https://curecurrent.com/trials/randomized-clinical-trial-to-assess-the-efficacy-and-safety-of-concomitant-use-of-rifampicin-and-efavirenz-600-x-800mg-131969https://curecurrent.com/trials/safety-and-acceptability-of-cabotegravir-in-hiv-uninfected-women-in-kwazulu-natal-south-africa-131970https://curecurrent.com/trials/human-immune-responses-toward-hiv-1-envelope-antigens-131971https://curecurrent.com/trials/enhanced-provision-of-male-circumcision-mc-for-hiv-prevention-rakai-uganda-131972https://curecurrent.com/trials/traditional-cam-therapy-in-the-treatment-of-hiv-aids-131973https://curecurrent.com/trials/wand-study-a-study-to-evaluate-fuzeon-enfuvirtide-administered-by-a-needle-free-injection-device-in-patients-with-hiv-131974https://curecurrent.com/trials/boss-study-a-study-of-fuzeon-using-the-needle-free-biojector-2000-in-patients-with-hiv-1-infection-131975https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-an-anti-hiv-drug-in-israeli-ethiopian-and-non-ethiopian-populations-131976https://curecurrent.com/trials/impact-of-pre-art-blood-cd4-t-cell-level-on-the-rectal-reservoir-in-long-term-hiv-1-treated-men-131977https://curecurrent.com/trials/rapid-hiv-testing-program-in-the-emergency-department-131978https://curecurrent.com/trials/three-dose-regimen-of-mrkad5-6-trigene-v526-in-healthy-adults-v526-001-completed-131979https://curecurrent.com/trials/management-of-human-immunodeficiency-virus-1-hiv-1-participants-treated-with-antiretroviral-arv-combination-therapy-incl-131980https://curecurrent.com/trials/reducing-unsafe-alcohol-use-in-hiv-positive-individuals-131981https://curecurrent.com/trials/a-phase-3-study-to-evaluate-combination-therapy-with-daclatasvir-and-sofosbuvir-in-the-treatment-of-hiv-and-hepatitis-c-131982https://curecurrent.com/trials/cogstim-a-pilot-study-cognitive-rehabilitation-management-of-hiv-1-mild-cognitively-impaired-patients-controlled-with-an-131983https://curecurrent.com/trials/bioequivalence-study-of-two-formulations-with-the-association-of-tenofovir-300-mg-and-emtricitabine-200-mg-131984https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-foscarnet-ganciclovir-cmv-retinitis-trial-fgcrt-131985https://curecurrent.com/trials/a-study-to-monitor-patients-with-primary-or-early-hiv-infection-131986https://curecurrent.com/trials/the-biology-of-hiv-transmission-131987https://curecurrent.com/trials/positive-lifestyles-using-safety-131988https://curecurrent.com/trials/study-to-determine-impact-of-feeding-buddies-on-adherence-to-who-pmtct-guidelines-in-south-africa-131989https://curecurrent.com/trials/safety-and-efficacy-study-of-non-surgical-mc-device-for-adolescent-male-population-including-contraindicated-subjects-131990https://curecurrent.com/trials/positive-change-agents-program-tanzania-evaluation-131991https://curecurrent.com/trials/effect-of-hiv-infection-and-highly-active-antiretroviral-treatment-haart-on-bone-homeostasis-131992https://curecurrent.com/trials/adhepta-study-adherence-questionnaire-in-hepatitis-c-131993https://curecurrent.com/trials/diarrhea-and-bivalent-oral-polio-vaccine-immunity-131994https://curecurrent.com/trials/emotional-disclosure-in-hiv-131995https://curecurrent.com/trials/rapid-hiv-testing-and-counseling-in-drug-abuse-treatment-131996https://curecurrent.com/trials/evaluation-of-an-innovative-tuberculosis-diagnostic-test-131997https://curecurrent.com/trials/venue-based-couples-coop-in-south-africa-131998https://curecurrent.com/trials/implementation-of-the-pre-exposure-prophylaxis-prep-to-hiv-a-demonstrative-project-131999https://curecurrent.com/trials/cervical-cancer-screening-in-hiv-positive-and-negative-women-in-cambodia-132000https://curecurrent.com/trials/investigation-of-v520-in-an-hiv-vaccine-proof-of-concept-study-v520-023-132001https://curecurrent.com/trials/gallium-nitrate-in-treating-patients-with-aids-related-non-hodgkin-s-lymphoma-132002https://curecurrent.com/trials/comparative-trial-of-antidepressant-treatment-models-in-hiv-care-in-uganda-132003https://curecurrent.com/trials/human-papilloma-virus-infection-in-hiv-positive-indian-men-who-have-sex-with-men-132004https://curecurrent.com/trials/development-of-method-of-fructose-identification-in-urine-to-detect-the-viral-infection-132005https://curecurrent.com/trials/hiv-1-vaccine-test-in-uninfected-adult-volunteers-132006https://curecurrent.com/trials/observational-study-of-antiretroviral-arv-response-in-a-cohort-of-african-children-using-viral-load-monitoring-132007https://curecurrent.com/trials/assessment-of-dolutegravir-removed-by-hemodialysis-in-hiv-infected-patients-with-end-stage-renal-disease-132008